Shariat, Shahrokh

Publications

Sort by

Co-Author Network

selected publications

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. 2023 GET IT
Comparison of different urinary diversions after radical cystectomy in Iran: Assessment of health-related quality of life and financial burden in a Middle Eastern country. Urologia. 2023 Academic Article GET IT
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. European urology. 2023 Review GET IT
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension. Prostate cancer and prostatic diseases. 2023 Academic Article GET IT
Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. European urology focus. 2023 Academic Article GET IT
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer. BJU international. 2023 Academic Article GET IT
Continent diversion is losing its momentum: a nationwide trend analysis from Germany 2005-2021. BJU international. 2023 Academic Article GET IT
[Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review]. Urologie (Heidelberg, Germany). 2023 Review GET IT
Characteristics of incidental prostate cancer in the United States. Prostate cancer and prostatic diseases. 2023 Academic Article GET IT
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010. European urology oncology. 2023 Letter GET IT
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis. International journal of urology : official journal of the Japanese Urological Association. 2023 Review GET IT
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. European urology oncology. 2023 Academic Article GET IT
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer. European urology oncology. 2023 Academic Article GET IT
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era. Annals of surgical oncology. 2023 Academic Article GET IT
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study. Prostate cancer and prostatic diseases. 2023 Academic Article GET IT
Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005. European urology focus. 2023 Letter GET IT
Times cited: 1
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy. Minerva urology and nephrology. 2023 Academic Article GET IT
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2023 Academic Article GET IT
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites. Urologic oncology. 2023 Academic Article GET IT
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA. World journal of urology. 2023 Academic Article GET IT
The diagnostic accuracy of ⁶⁸ Ga-PSMA-PET/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: A single-center cohort analysis. The Prostate. 2023 Academic Article GET IT
Antihormonal-Treatment Status Affects ⁶⁸Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Academic Article GET IT
In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery. Annals of surgical oncology. 2023 Academic Article GET IT
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma. Urologic oncology. 2023 Academic Article GET IT
Times cited: 1
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer. Urologic oncology. 2023 Academic Article GET IT
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis. Immunotherapy. 2023 Review GET IT
Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium. European urology focus. 2023 Academic Article GET IT
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis. Cancers. 2023 Academic Article GET IT
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters. European urology oncology. 2023 Academic Article GET IT
Direct Patlak Reconstruction of [⁶⁸Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study. International journal of molecular sciences. 2023 Academic Article GET IT
Regional differences in metastatic urothelial carcinoma of the urinary bladder patients across the United States SEER registries. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2023 Academic Article GET IT
Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls. International urology and nephrology. 2023 Academic Article GET IT
En bloc resection of bladder tumour: the rebirth of past through reminiscence. World journal of urology. 2023 Review GET IT
Times cited: 6
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites. Clinical genitourinary cancer. 2023 Academic Article GET IT
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis. BJU international. 2023 Review GET IT
Reply to Kun-Peng Li, Shun Wan, Chen-Yang Wang, and Li Yang's Letter to the Editor re: Tatsushi Kawada, Ekaterina Laukhtina, Fahad Quhal, et al. Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis. Eur Urol Focus 2023;9:236-40. European urology focus. 2023 Letter GET IT
Times cited: 1
Conditional survival of stage III non-seminoma testis cancer patients. Urologic oncology. 2023 Academic Article GET IT
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations. The Prostate. 2023 Academic Article GET IT
En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. European urology oncology. 2023 Academic Article GET IT
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer. World journal of urology. 2023 Academic Article GET IT
Times cited: 2
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registries. Minerva urology and nephrology. 2023 Academic Article GET IT
Regional differences in penile cancer patient characteristics and treatment rates across the United States. Cancer epidemiology. 2023 Academic Article GET IT
Times cited: 1
Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era. European urology focus. 2023 Review GET IT
Times cited: 1
Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function. European urology focus. 2023 Review GET IT
Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis. Immunotherapy. 2023 Review GET IT
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta-analysis. BJU international. 2023 Review GET IT
Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes. World journal of urology. 2023 Review GET IT
Times cited: 5
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis. The Journal of urology. 2023 Review GET IT
Times cited: 1
Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. European urology focus. 2023 Academic Article GET IT
Times cited: 3
Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy. Minerva urology and nephrology. 2023 Academic Article GET IT
Times cited: 1
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma. European urology open science. 2023 Academic Article GET IT
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy. Clinical genitourinary cancer. 2023 Academic Article GET IT
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma. World journal of urology. 2023 Academic Article GET IT
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy. Cancers. 2023 Academic Article GET IT
African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients. Endocrine-related cancer. 2023 Academic Article GET IT
Cancer-specific mortality free survival rates in non-metastatic non-clear cell renal carcinoma patients at intermediate/high risk of recurrence. Minerva urology and nephrology. 2023 Academic Article GET IT
Times cited: 1
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool. European urology oncology. 2023 Academic Article GET IT
Times cited: 12
Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. European urology. 2023 Comment GET IT
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence. Cancers. 2023 Review GET IT
Times cited: 4
Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis. World journal of urology. 2023 Review GET IT
Times cited: 11
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion. Clinical genitourinary cancer. 2023 Academic Article GET IT
Reply to Huseyin Besiroglu's Letter to the Editor regarding the article 'Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?'. BJU international. 2023 Letter GET IT
Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer. Current opinion in urology. 2023 Review GET IT
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members. European urology open science. 2023 Academic Article GET IT
The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis. Urologic oncology. 2023 Review GET IT
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer. Central European journal of urology. 2023 Academic Article GET IT
Conditional survival for non-metastatic muscle-invasive adenocarcinoma of the urinary bladder after radical cystectomy. Surgical oncology. 2023 Academic Article GET IT
Times cited: 1
Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis. BJU international. 2023 Review GET IT
Times cited: 1
What is the role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?. Expert review of anticancer therapy. 2023 Editorial Article GET IT
Times cited: 2
Role of lymphadenectomy during primary surgery for kidney cancer. Current opinion in urology. 2023 Review GET IT
Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review. Journal of personalized medicine. 2023 Review GET IT
Times cited: 3
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma. Cancers. 2023 Academic Article GET IT
Times cited: 4
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023. Current opinion in urology. 2023 Review GET IT
Times cited: 4
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer. European urology open science. 2023 Academic Article GET IT
Times cited: 2
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. European urology. 2023 Review GET IT
Times cited: 215
A Review of How Lasers Are Used in UTUC Surgery: Can the Choice of Laser Affect Outcomes?. Cancers. 2023 Review GET IT
Times cited: 4
Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis. International journal of molecular sciences. 2023 Review GET IT
Times cited: 8
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy. The Prostate. 2023 Academic Article GET IT
ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?. Annals of surgical oncology. 2023 Comment GET IT
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis. Annals of surgical oncology. 2023 Academic Article GET IT
Times cited: 21
Regional differences in total hospital costs for radical cystectomy in the United States. Surgical oncology. 2023 Academic Article GET IT
Times cited: 1
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. European urology focus. 2023 Academic Article GET IT
Times cited: 2
PET in bladder cancer imaging. Current opinion in urology. 2023 Review GET IT
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer. Urologic oncology. 2023 Academic Article GET IT
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2023 Academic Article GET IT
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. 2023 GET IT
Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages. Medicina (Kaunas, Lithuania). 2023 Academic Article GET IT
Times cited: 2
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis. Cancers. 2023 Academic Article GET IT
Times cited: 12
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities. International urology and nephrology. 2023 Academic Article GET IT
Times cited: 1
The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer. Journal of clinical medicine. 2023 Academic Article GET IT
Times cited: 7
From Avoiding Overtreatment and Undertreatment to Delivering the Right Therapy at the Right Time for the Right Tumor in the Right Patient: The Age of the Thoughtful Urologic Oncologic Surgeon Has Begun. European urology focus. 2023 Editorial Article GET IT
Times cited: 1
Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review. European urology focus. 2023 Review GET IT
Times cited: 1
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU international. 2023 Academic Article GET IT
Times cited: 14
Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?. European urology open science. 2023 Academic Article GET IT
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort. The Journal of urology. 2023 Academic Article GET IT
Times cited: 5
Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking. Clinical genitourinary cancer. 2023 Academic Article GET IT
Times cited: 3
Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity. Cancers. 2023 Academic Article GET IT
Times cited: 5
An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer. Current oncology (Toronto, Ont.). 2023 Review GET IT
Times cited: 3
Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma. European urology focus. 2023 Review GET IT
Times cited: 3
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis. European urology focus. 2023 Review GET IT
Increase and Plateauing of Testicular Cancer Incidence in Austria-A Time Trend Analysis of the Past Four Decades. European urology open science. 2023 Academic Article GET IT
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer. Current oncology (Toronto, Ont.). 2023 Academic Article GET IT
Times cited: 1
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy. Clinical genitourinary cancer. 2023 Academic Article GET IT
Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials. Current opinion in urology. 2023 Review GET IT
Times cited: 3
Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports. European urology focus. 2023 Review GET IT
Times cited: 4
Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages. Cancers. 2023 Academic Article GET IT
Times cited: 3
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy. The Prostate. 2023 Academic Article GET IT
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort. European urology focus. 2023 Academic Article GET IT
Times cited: 3
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. European urology oncology. 2023 Academic Article GET IT
Times cited: 10
Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis. BJU international. 2023 Review GET IT
Times cited: 1
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States. Annals of epidemiology. 2023 Academic Article GET IT
Times cited: 1
Inherited mutations in Chinese patients with upper tract urothelial carcinoma. Cell reports. Medicine. 2023 Academic Article GET IT
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?. Current opinion in urology. 2023 Review GET IT
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations. Nature reviews. Urology. 2023 Review GET IT
Times cited: 6
The microbiome of kidney stones and urine of patients with nephrolithiasis. Urolithiasis. 2023 Academic Article GET IT
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification. The Journal of urology. 2022 Academic Article GET IT
Times cited: 1
The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. Cells. 2022 Academic Article GET IT
Times cited: 8
Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer. The Prostate. 2022 Academic Article GET IT
Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis. Current opinion in urology. 2022 Review GET IT
Times cited: 4
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer. European urology focus. 2022 Review GET IT
Times cited: 3
Cytoreductive Surgery in Patients with Urothelial Bladder Cancer. European urology focus. 2022 Academic Article GET IT
Times cited: 1
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study. The Journal of urology. 2022 Academic Article GET IT
Times cited: 5
Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations. Frontiers in oncology. 2022 Academic Article GET IT
Times cited: 1
Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder. Urologic oncology. 2022 Academic Article GET IT
Times cited: 1
Comment on: "Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society". Minerva urology and nephrology. 2022 Comment GET IT
Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms. The aging male : the official journal of the International Society for the Study of the Aging Male. 2022 Academic Article GET IT
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis. European urology focus. 2022 Review GET IT
Times cited: 10
Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond. Expert opinion on pharmacotherapy. 2022 Review GET IT
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma. The Journal of urology. 2022 Academic Article GET IT
Times cited: 4
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival. Urologic oncology. 2022 Academic Article GET IT
Times cited: 1
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis. Journal of surgical oncology. 2022 Academic Article GET IT
Times cited: 2
Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients. Central European journal of urology. 2022 Academic Article GET IT
Times cited: 3
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis. Clinical genitourinary cancer. 2022 Academic Article GET IT
Times cited: 1
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype. Cancers. 2022 Academic Article GET IT
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. Urologic oncology. 2022 Academic Article GET IT
Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis. European urology focus. 2022 Review GET IT
Times cited: 5
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy. Arab journal of urology. 2022 Academic Article GET IT
Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma. Cancer epidemiology. 2022 Academic Article GET IT
A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer. Clinical genitourinary cancer. 2022 Review GET IT
Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review. European urology focus. 2022 Review GET IT
Times cited: 1
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy. International journal of urology : official journal of the Japanese Urological Association. 2022 Academic Article GET IT
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5. The Prostate. 2022 Academic Article GET IT
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators. BJU international. 2022 Academic Article GET IT
Times cited: 3
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients. Anticancer research. 2022 Academic Article GET IT
Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review. Translational andrology and urology. 2022 Review GET IT
Times cited: 10
Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review. Journal of clinical medicine. 2022 Review GET IT
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. Prostate cancer and prostatic diseases. 2022 Review GET IT
Times cited: 3
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time. Seminars in oncology. 2022 Review GET IT
Times cited: 2
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urologic oncology. 2022 Academic Article GET IT
Times cited: 11
Robot-Assisted Partial Nephrectomy Mid-Term Oncologic Outcomes: A Systematic Review. Journal of clinical medicine. 2022 Review GET IT
Times cited: 13
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis. BJU international. 2022 Review GET IT
Times cited: 1
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis. World journal of urology. 2022 Academic Article GET IT
Update on Flat and Papillary Urothelial Lesions: Genitourinary Pathology Society Consensus Recommendations. Surgical pathology clinics. 2022 Review GET IT
Times cited: 1
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity. World journal of urology. 2022 Academic Article GET IT
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium). World journal of urology. 2022 Academic Article GET IT
Times cited: 15
The current role of precision surgery in oligometastatic prostate cancer. ESMO open. 2022 Review GET IT
Times cited: 13
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registry. World journal of urology. 2022 Academic Article GET IT
Times cited: 1
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Frontiers in surgery. 2022 Review GET IT
Times cited: 7
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate. BJU international. 2022 Academic Article GET IT
Times cited: 2
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer. World journal of urology. 2022 Academic Article GET IT
Times cited: 1
Radical cystectomy in non-metastatic sarcomatoid bladder cancer: A direct comparison vs urothelial bladder cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Academic Article GET IT
Times cited: 1
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases. Nuclear medicine communications. 2022 Academic Article GET IT
Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes. Current opinion in urology. 2022 Review GET IT
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy. European urology open science. 2022 Academic Article GET IT
Times cited: 3
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma. Clinical genitourinary cancer. 2022 Academic Article GET IT
Times cited: 1
Online Crowdfunding for Urologic Cancer Care. Cancers. 2022 Academic Article GET IT
Times cited: 3
Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries. Current urology. 2022 Academic Article GET IT
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. European urology. 2022 Review GET IT
Times cited: 31
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy. Frontiers in oncology. 2022 Academic Article GET IT
Times cited: 2
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis. World journal of urology. 2022 Review GET IT
Times cited: 8
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis. Urologic oncology. 2022 Review GET IT
Times cited: 2
[Granting of venia legendi as an indicator of specialization : Victor von Ivánchich de Margita (1812-1892) "Lecturer for surgery of the urogenital organs" in Vienna in 1851]. Urologie (Heidelberg, Germany). 2022 Academic Article GET IT
Times cited: 1
External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy. World journal of urology. 2022 Academic Article GET IT
Times cited: 3
Contrast-enhanced CT texture analysis for the prediction of delayed graft function following kidney transplantation from cadaveric donors. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2022 Academic Article GET IT
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer. BJUI compass. 2022 Academic Article GET IT
Times cited: 3
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy. European urology focus. 2022 Academic Article GET IT
Times cited: 4
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis. Scientific reports. 2022 Academic Article GET IT
Times cited: 3
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity. Urologic oncology. 2022 Academic Article GET IT
Times cited: 3
Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma. Urologic oncology. 2022 Academic Article GET IT
Times cited: 4
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?. Current opinion in urology. 2022 Review GET IT
Times cited: 1
Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis. Current opinion in urology. 2022 Review GET IT
Times cited: 2
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer. Central European journal of urology. 2022 Academic Article GET IT
Times cited: 2
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer. Urologic oncology. 2022 Academic Article GET IT
Times cited: 6
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients. International urology and nephrology. 2022 Academic Article GET IT
Times cited: 5
Brief update of the new WHO classification for urothelial carcinoma. Current opinion in urology. 2022 Review GET IT
Times cited: 3
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder. Current opinion in urology. 2022 Review GET IT
Times cited: 4
The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review. Journal of clinical medicine. 2022 Review GET IT
Times cited: 5
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core. Urologic oncology. 2022 Academic Article GET IT
Times cited: 1
Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population. European journal of radiology. 2022 Academic Article GET IT
Times cited: 18
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery. Frontiers in oncology. 2022 Article GET IT
Times cited: 9
Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. Current opinion in urology. 2022 Review GET IT
Times cited: 4
Nonmuscle-invasive bladder cancer, old problems, new insights. Current opinion in urology. 2022 Review GET IT
Re: Lymph Node Colonization Induces Tumor-immune Tolerance To Promote Distant Metastasis. European urology. 2022 Academic Article GET IT
Times cited: 2
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer. The Prostate. 2022 Academic Article GET IT
Times cited: 1
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines. European urology focus. 2022 Review GET IT
Times cited: 6
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. Current opinion in urology. 2022 Review GET IT
Times cited: 3
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. European urology oncology. 2022 Review GET IT
Times cited: 14
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. European urology oncology. 2022 Review GET IT
Times cited: 17
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. European urology oncology. 2022 Academic Article GET IT
Times cited: 6
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery. European urology open science. 2022 Academic Article GET IT
Times cited: 5
Outcomes of robotic-assisted versus open radical cystectomy in a large-scale, contemporary cohort of bladder cancer patients. Journal of surgical oncology. 2022 Academic Article GET IT
Times cited: 5
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level. The Prostate. 2022 Academic Article GET IT
Times cited: 2
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362. 2022 GET IT
The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy. European urology open science. 2022 Academic Article GET IT
Times cited: 7
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis. World journal of urology. 2022 Academic Article GET IT
Times cited: 7
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study. World journal of urology. 2022 Academic Article GET IT
Times cited: 6
Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis. European urology open science. 2022 Review GET IT
Times cited: 3
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. Surgical oncology. 2022 Academic Article GET IT
Times cited: 2
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations. European urology oncology. 2022 Review GET IT
Times cited: 7
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum. European urology focus. 2022 Academic Article GET IT
Times cited: 2
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?. BJU international. 2022 Academic Article GET IT
Times cited: 19
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma. European urology focus. 2022 Review GET IT
Times cited: 4
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis. Urologic oncology. 2022 Review GET IT
Times cited: 10
Feasibility and Optimal Time Point of [⁶⁸Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery. European urology open science. 2022 Academic Article GET IT
Times cited: 1
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity. International urology and nephrology. 2022 Academic Article GET IT
Times cited: 8
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma. European urology oncology. 2022 Academic Article GET IT
Times cited: 8
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. European urology. 2022 Academic Article GET IT
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab. Seminars in oncology. 2022 Academic Article GET IT
Times cited: 2
Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis. Immunotherapy. 2022 Review GET IT
Times cited: 6
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis. International journal of surgical pathology. 2022 Academic Article GET IT
Times cited: 2
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. European urology. 2022 Review GET IT
Times cited: 12
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients. Clinical genitourinary cancer. 2022 Academic Article GET IT
Times cited: 4
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. Urologic oncology. 2022 Academic Article GET IT
Times cited: 10
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?. Annals of surgical oncology. 2022 Comment GET IT
Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis. Prostate cancer and prostatic diseases. 2022 Review GET IT
Times cited: 7
Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients. The Prostate. 2022 Academic Article GET IT
Times cited: 7
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound. European urology. 2022 Academic Article GET IT
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy. International journal of urology : official journal of the Japanese Urological Association. 2022 Academic Article GET IT
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study. European urology open science. 2022 Academic Article GET IT
Times cited: 9
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidates. The Prostate. 2022 Academic Article GET IT
Times cited: 6
Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review. Translational cancer research. 2022 Review GET IT
Times cited: 2
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics. Cancers. 2022 Academic Article GET IT
Times cited: 3
Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nature reviews. Urology. 2022 Review GET IT
Times cited: 23
Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. European urology. 2022 Review GET IT
Times cited: 19
Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis. Arab journal of urology. 2022 Review GET IT
Times cited: 2
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer. World journal of urology. 2022 Academic Article GET IT
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Annals of surgical oncology. 2022 Academic Article GET IT
The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis. International immunopharmacology. 2022 Review GET IT
Times cited: 9
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group. European urology focus. 2022 Review GET IT
Times cited: 3
Recent pharmacological approaches for the treatment of renal cell carcinoma. Expert review of clinical pharmacology. 2022 Academic Article GET IT
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2022 Academic Article GET IT
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival. Clinical genitourinary cancer. 2022 Academic Article GET IT
Times cited: 1
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis. European urology focus. 2022 Review GET IT
Times cited: 7
En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. Current opinion in urology. 2022 Review GET IT
Radiation therapy after radical prostatectomy is associated with higher other-cause mortality. Cancer causes & control : CCC. 2022 Academic Article GET IT
Times cited: 1
MRI as a screening tool for prostate cancer: current evidence and future challenges. World journal of urology. 2022 Review GET IT
Times cited: 14
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancer. The Prostate. 2022 Academic Article GET IT
Times cited: 6
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis. Urologic oncology. 2022 Review GET IT
Times cited: 8
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists. Urologic oncology. 2022 Academic Article GET IT
Times cited: 5
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy. Cancers. 2022 Academic Article GET IT
Times cited: 8
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration. World journal of urology. 2022 Academic Article GET IT
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?. Urologic oncology. 2022 Academic Article GET IT
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups. The Prostate. 2022 Academic Article GET IT
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients. The Prostate. 2022 Academic Article GET IT
Prospective two-arm study of the testicular function in patients with COVID-19. Andrology. 2022 Academic Article GET IT
Times cited: 39
Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables. Journal of racial and ethnic health disparities. 2022 Academic Article GET IT
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer. World journal of urology. 2022 Academic Article GET IT
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysis. Scandinavian journal of urology. 2022 Review GET IT
Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art. Current oncology (Toronto, Ont.). 2022 Review GET IT
Times cited: 17
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients. World journal of urology. 2022 Academic Article GET IT
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer. Prostate international. 2022 Academic Article GET IT
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study. Clinical genitourinary cancer. 2022 Academic Article GET IT
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer. Journal of cancer research and clinical oncology. 2022 Academic Article GET IT
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies. Molecular cancer. 2022 Letter GET IT
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy. European urology oncology. 2022 Academic Article GET IT
Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics. European journal of radiology. 2022 Academic Article GET IT
Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis. Current opinion in urology. 2022 Review GET IT
Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis. Journal of robotic surgery. 2021 Review GET IT
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer. Journal of cellular and molecular medicine. 2021 Academic Article GET IT
Times cited: 4
The placebo and nocebo effects in functional urology. Nature reviews. Urology. 2021 Review GET IT
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients. Urologic oncology. 2021 Academic Article GET IT
Times cited: 31
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy. Clinical genitourinary cancer. 2021 Academic Article GET IT
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Critical reviews in oncology/hematology. 2021 Review GET IT
Times cited: 1
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors. European urology oncology. 2021 Review GET IT
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysis. Central European journal of urology. 2021 Review GET IT
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients. Frontiers in oncology. 2021 Academic Article GET IT
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis. Critical reviews in oncology/hematology. 2021 Review GET IT
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy. Urologic oncology. 2021 Academic Article GET IT
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy. Journal of personalized medicine. 2021 Academic Article GET IT
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate. International urology and nephrology. 2021 Academic Article GET IT
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data. Frontiers in surgery. 2021 Academic Article GET IT
Times cited: 3
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients. International journal of urology : official journal of the Japanese Urological Association. 2021 Letter GET IT
Times cited: 3
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients. International urology and nephrology. 2021 Academic Article GET IT
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis. International journal of clinical oncology. 2021 Review GET IT
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder. Clinical genitourinary cancer. 2021 Academic Article GET IT
Times cited: 3
Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations. Journal of personalized medicine. 2021 Academic Article GET IT
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria. Cancers. 2021 Academic Article GET IT
Times cited: 31
Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries. Journal of psychiatric research. 2021 Academic Article GET IT
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies. World journal of urology. 2021 Academic Article GET IT
Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach. World journal of urology. 2021 Academic Article GET IT
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma. Urologic oncology. 2021 Academic Article GET IT
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients. The Prostate. 2021 Academic Article GET IT
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2021 Academic Article GET IT
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials. Seminars in oncology. 2021 Review GET IT
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Molecular carcinogenesis. 2021 Academic Article GET IT
Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783-92. European urology. 2021 Letter GET IT
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. The Journal of urology. 2021 Academic Article GET IT
Times cited: 4
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Current oncology (Toronto, Ont.). 2021 Academic Article GET IT
Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis. European urology focus. 2021 Review GET IT
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients. International journal of urology : official journal of the Japanese Urological Association. 2021 Academic Article GET IT
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. The Journal of urology. 2021 Review GET IT
Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations. Journal of personalized medicine. 2021 Academic Article GET IT
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients. The Prostate. 2021 Academic Article GET IT
Times cited: 3
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant. The Prostate. 2021 Academic Article GET IT
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). European urology. 2021 Review GET IT
Times cited: 10
Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis. World journal of urology. 2021 Review GET IT
Times cited: 18
Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study. International journal of urology : official journal of the Japanese Urological Association. 2021 Academic Article GET IT
Times cited: 2
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma. Cancer causes & control : CCC. 2021 Academic Article GET IT
Editorial: Lower urinary tract symptoms, benign prostate hyperplasia and beyond. Current opinion in urology. 2021 Editorial Article GET IT
Times cited: 1
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients. Clinical genitourinary cancer. 2021 Academic Article GET IT
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer. The Journal of urology. 2021 Academic Article GET IT
Times cited: 1
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy. World journal of urology. 2021 Academic Article GET IT
Times cited: 2
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. European urology focus. 2021 Academic Article GET IT
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. European urology focus. 2021 Academic Article GET IT
Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis. Urologic oncology. 2021 Review GET IT
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis. European journal of cancer. 2021 Review GET IT
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology. 2021 Academic Article GET IT
Times cited: 5
Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries. Cancer epidemiology. 2021 Academic Article GET IT
Times cited: 2
Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab. International journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 4
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy. European urology focus. 2021 Academic Article GET IT
Times cited: 2
Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response. Current oncology (Toronto, Ont.). 2021 Review GET IT
Times cited: 17
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. Urologic oncology. 2021 Academic Article GET IT
Times cited: 3
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients. The Prostate. 2021 Academic Article GET IT
Times cited: 4
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis. Urologic oncology. 2021 Review GET IT
Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19. Current opinion in urology. 2021 Review GET IT
Times cited: 8
Artificial intelligence in prostate histopathology: where are we in 2021?. Current opinion in urology. 2021 Review GET IT
Times cited: 4
COVID-19 crisis and minimally invasive surgery: a narrative review on intraoperative aerosol viral transmission and their impact on guidelines and clinical practice in Austria. Current opinion in urology. 2021 Review GET IT
Contemporary patterns of presentation, diagnostics and management of upper tract urothelial cancer in 101 centres: the Clinical Research Office of the Endourological Society Global upper tract urothelial carcinoma registry. Current opinion in urology. 2021 Academic Article GET IT
Times cited: 1
Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 2. Current opinion in urology. 2021 Review GET IT
Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1. Current opinion in urology. 2021 Review GET IT
Times cited: 1
Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review. Current opinion in urology. 2021 Review GET IT
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines. ESMO open. 2021 Academic Article GET IT
Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Japanese journal of clinical oncology. 2021 Academic Article GET IT
Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy. Current opinion in urology. 2021 Review GET IT
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival. World journal of urology. 2021 Academic Article GET IT
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Advances in anatomic pathology. 2021 Guideline GET IT
Times cited: 29
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Advances in anatomic pathology. 2021 Guideline GET IT
Times cited: 28
The prognostic value of sarcopenia in patients with prostate cancer: a systematic review. Current opinion in urology. 2021 Academic Article GET IT
Times cited: 1
Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta-Analysis. Cancers. 2021 Review GET IT
Times cited: 10
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. The Journal of urology. 2021 Academic Article GET IT
Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. International journal of clinical oncology. 2021 Academic Article GET IT
Difference in Incontinence Pad Use between Patients after Radical Prostatectomy and Cancer-Free Population with Subgroup Analysis for Open vs. Minimally Invasive Radical Prostatectomy: A Descriptive Analysis of Insurance Claims-Based Data. International journal of environmental research and public health. 2021 Academic Article GET IT
Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis. BJU international. 2021 Review GET IT
Times cited: 7
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. European urology oncology. 2021 Academic Article GET IT
Times cited: 8
Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?. European journal of radiology. 2021 Academic Article GET IT
Times cited: 1
ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?. Annals of surgical oncology. 2021 Academic Article GET IT
Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis. International journal of clinical oncology. 2021 Review GET IT
Times cited: 16
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer. World journal of urology. 2021 Academic Article GET IT
Times cited: 21
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. Actas urologicas espanolas. 2021 Academic Article GET IT
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis. Cancer treatment reviews. 2021 Review GET IT
Times cited: 3
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis. European urology focus. 2021 Review GET IT
Impact of the preoperative modified glasgow prognostic score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. Minerva urology and nephrology. 2021 Academic Article GET IT
Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer. Annals of surgical oncology. 2021 Academic Article GET IT
Times cited: 4
Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer. Urologic oncology. 2021 Academic Article GET IT
Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy. International journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 5
Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study. Urologic oncology. 2021 Academic Article GET IT
Times cited: 1
Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. European urology focus. 2021 Review GET IT
Times cited: 1
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. The New England journal of medicine. 2021 Academic Article GET IT
Times cited: 582
Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. European urology oncology. 2021 Academic Article GET IT
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns. The Prostate. 2021 Academic Article GET IT
Times cited: 1
The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer. The Prostate. 2021 Academic Article GET IT
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Prostate cancer and prostatic diseases. 2021 Review GET IT
Times cited: 3
Sex- and age-related differences in the distribution of bladder cancer metastases. Japanese journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 1
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy. The Journal of urology. 2021 Academic Article GET IT
Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review. The Journal of urology. 2021 Academic Article GET IT
Times cited: 1
Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. Cancer immunology, immunotherapy : CII. 2021 Academic Article GET IT
Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis. Cancers. 2021 Review GET IT
Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. European urology. 2021 Academic Article GET IT
Times cited: 2
Response and Toxicity to the Second Course of 3 Cycles of ¹⁷⁷Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 2021 Academic Article GET IT
Times cited: 6
Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy. The Prostate. 2021 Academic Article GET IT
Times cited: 6
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis. European urology. 2021 Review GET IT
Times cited: 8
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy. World journal of urology. 2021 Academic Article GET IT
Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups. International journal of urology : official journal of the Japanese Urological Association. 2021 Academic Article GET IT
Times cited: 6
The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients. Urologic oncology. 2021 Academic Article GET IT
Times cited: 2
Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities. World journal of urology. 2021 Academic Article GET IT
Times cited: 12
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis. European journal of cancer. 2021 Review GET IT
Times cited: 5
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials. BJU international. 2021 Review GET IT
Times cited: 22
Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?. Current opinion in urology. 2021 Review GET IT
Times cited: 1
Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis. Current opinion in urology. 2021 Review GET IT
Times cited: 1
What is next in second- and later-line treatment of metastatic renal cell carcinoma? review of the recent literature. Current opinion in urology. 2021 Review GET IT
Times cited: 2
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy. European urology focus. 2021 Academic Article GET IT
Times cited: 4
Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2021 Academic Article GET IT
Discrepancies between staff and gold standard ratings of schizophrenia symptom severity. Psychiatry research. 2021 Letter GET IT
Times cited: 1
Partial nephrectomy in frail patients: Benefits of robot-assisted surgery. Surgical oncology. 2021 Academic Article GET IT
Times cited: 1
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. Urologic oncology. 2021 Review GET IT
Times cited: 2
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9. European urology focus. 2021 Letter GET IT
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis. European urology focus. 2021 Review GET IT
Times cited: 5
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis. Clinical genitourinary cancer. 2021 Academic Article GET IT
Times cited: 15
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. BJU international. 2021 Academic Article GET IT
Times cited: 3
Reply by Authors. The Journal of urology. 2021 Comment GET IT
Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview. Journal of psychopharmacology (Oxford, England). 2021 Academic Article GET IT
Times cited: 14
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Minerva urology and nephrology. 2021 Academic Article GET IT
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. European urology focus. 2021 Academic Article GET IT
Times cited: 2
Incidence rates and contemporary trends in primary urethral cancer. Cancer causes & control : CCC. 2021 Academic Article GET IT
Times cited: 18
The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma. Urology. 2021 Academic Article GET IT
Times cited: 2
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence. European urology focus. 2021 Review GET IT
Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries. Clinical genitourinary cancer. 2021 Academic Article GET IT
Times cited: 1
Association Between Body Fat Mass and Kidney Stones in US Adults: Analysis of the National Health and Nutrition Examination Survey 2011-2018. European urology focus. 2021 Academic Article GET IT
Times cited: 1
Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy. European urology focus. 2021 Academic Article GET IT
Times cited: 3
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer. World journal of urology. 2021 Academic Article GET IT
Times cited: 8
Prevalence and trends in urinary incontinence among women in the United States, 2005-2018. American journal of obstetrics and gynecology. 2021 Academic Article GET IT
Times cited: 4
Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients. Urologia internationalis. 2021 Academic Article GET IT
Times cited: 1
Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer. The Journal of urology. 2021 Academic Article GET IT
Times cited: 5
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. The Prostate. 2021 Academic Article GET IT
Times cited: 7
Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method. Journal of clinical medicine. 2021 Academic Article GET IT
Times cited: 26
Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis. European urology focus. 2021 Review GET IT
Times cited: 4
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors. World journal of urology. 2021 Academic Article GET IT
Times cited: 6
The microbiome in urinary tract infections in children - an update. Current opinion in urology. 2021 Review GET IT
Times cited: 1
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. European urology focus. 2021 Academic Article GET IT
Times cited: 5
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. Urologic oncology. 2021 Review GET IT
Times cited: 5
Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder. Journal of clinical pathology. 2021 Academic Article GET IT
Times cited: 2
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients. European urology focus. 2021 Academic Article GET IT
Times cited: 2
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. Urologic oncology. 2021 Academic Article GET IT
Times cited: 1
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Cancer immunology, immunotherapy : CII. 2021 Academic Article GET IT
Times cited: 25
A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer Diagnosis. The Journal of urology. 2021 Academic Article GET IT
Times cited: 4
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2021 Academic Article GET IT
Times cited: 12
Standardized training in the rating of the six-item Positive And Negative Syndrome Scale (PANSS-6). Schizophrenia research. 2021 Academic Article GET IT
Times cited: 1
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. Journal of clinical medicine. 2021 Review GET IT
Times cited: 11
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Translational andrology and urology. 2021 Academic Article GET IT
Times cited: 7
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma. International journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 4
Comparison Between Urothelial and Non-Urothelial Urethral Cancer. Frontiers in oncology. 2021 Academic Article GET IT
Times cited: 10
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis. International journal of clinical oncology. 2021 Review GET IT
Times cited: 13
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer. World journal of urology. 2021 Academic Article GET IT
Times cited: 18
Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?. European urology. 2021 Letter GET IT
Penile Rehabilitation Strategy after Nerve Sparing Radical Prostatectomy: A Systematic Review and Network Meta-Analysis of Randomized Trials. The Journal of urology. 2021 Review GET IT
Times cited: 2
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2021 Academic Article GET IT
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets. OncoTargets and therapy. 2021 Review GET IT
Times cited: 7
Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review. Cancers. 2021 Review GET IT
Times cited: 8
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. European urology oncology. 2021 Academic Article GET IT
Times cited: 12
Dual immune checkpoint inhibition in metastatic renal cell carcinoma: Editorial re.: Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced RCC: extended 4-year follow-up of the phase III CheckMate 214 trial. ESMO open. 2021 Editorial Article GET IT
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. European urology. 2021 Academic Article GET IT
Times cited: 254
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. Clinical genitourinary cancer. 2021 Academic Article GET IT
Times cited: 3
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer. Surgical oncology. 2021 Academic Article GET IT
Times cited: 1
Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy. European urology oncology. 2020 Review GET IT
Times cited: 5
Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020 Academic Article GET IT
Times cited: 4
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. The Journal of urology. 2020 Academic Article GET IT
Times cited: 21
Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer. European urology. 2020 Comment GET IT
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [⁶⁸Ga]Ga-PSMA-11 PET/MRI. European journal of nuclear medicine and molecular imaging. 2020 Academic Article GET IT
Times cited: 76
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer. Surgical oncology. 2020 Academic Article GET IT
Times cited: 1
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer. Urologic oncology. 2020 Academic Article GET IT
Times cited: 2
Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review. Arab journal of urology. 2020 Review GET IT
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study. Nutrition and cancer. 2020 Academic Article GET IT
Times cited: 1
Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. European urology oncology. 2020 Academic Article GET IT
Times cited: 8
Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma. Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 31
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?. European radiology. 2020 Academic Article GET IT
Times cited: 10
Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis Across Disease Stages. American journal of clinical oncology. 2020 Academic Article GET IT
Times cited: 1
Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape. Psychological medicine. 2020 Academic Article GET IT
Times cited: 58
Clinical Impact and Statistical Significance of Multiparametric Magnetic Resonance Imaging for Local Staging of Prostate Cancer. European urology. 2020 Editorial Article GET IT
Times cited: 2
Bladder cancer stage and mortality: urban vs. rural residency. Cancer causes & control : CCC. 2020 Academic Article GET IT
Times cited: 13
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis. BJU international. 2020 Academic Article GET IT
Times cited: 1
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas. Cancer causes & control : CCC. 2020 Academic Article GET IT
Times cited: 2
Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis. BJU international. 2020 Review GET IT
Times cited: 3
The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. European urology. 2020 Review GET IT
Times cited: 15
Association of Prostate Cancer with Nuts, Seeds, Alcohol and Processed Meats: A Worldwide Population-Based Study. Nutrition and cancer. 2020 Academic Article GET IT
Times cited: 1
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020 Academic Article GET IT
Times cited: 2
Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis. European urology focus. 2020 Review GET IT
Times cited: 2
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients. Journal of the National Comprehensive Cancer Network : JNCCN. 2020 Academic Article GET IT
Times cited: 4
A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 7
Pathomics in urology. Current opinion in urology. 2020 Review GET IT
Times cited: 6
Racial differences in the distribution of bladder cancer metastases: a population-based analysis. Central European journal of urology. 2020 Academic Article GET IT
Times cited: 5
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer. International journal of cancer. 2020 Academic Article GET IT
Times cited: 17
Prediction of response and survival after standardized treatment with 7400 MBq ¹⁷⁷Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European journal of nuclear medicine and molecular imaging. 2020 Academic Article GET IT
Times cited: 26
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU international. 2020 Academic Article GET IT
Times cited: 11
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy. Urologic oncology. 2020 Academic Article GET IT
Times cited: 3
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis. Urologic oncology. 2020 Academic Article GET IT
Times cited: 10
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer. European urology focus. 2020 Academic Article GET IT
Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2020 Academic Article GET IT
Times cited: 10
Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [⁶⁸Ga]Ga-PSMA ligand PET/CT(MRI). Prostate cancer and prostatic diseases. 2020 Academic Article GET IT
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. Minerva urology and nephrology. 2020 Academic Article GET IT
Times cited: 1
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. European urology. 2020 Comment GET IT
Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. European urology. 2020 Academic Article GET IT
Times cited: 23
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Urologic oncology. 2020 Academic Article GET IT
Times cited: 2
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study. European urology focus. 2020 Academic Article GET IT
Times cited: 1
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC). Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 5
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. International journal of clinical oncology. 2020 Review GET IT
Times cited: 62
Prevalence and Trends in Kidney Stone Among Adults in the USA: Analyses of National Health and Nutrition Examination Survey 2007-2018 Data. European urology focus. 2020 Academic Article GET IT
Times cited: 10
The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis. Urologic oncology. 2020 Review GET IT
Times cited: 3
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab journal of urology. 2020 Academic Article GET IT
Times cited: 10
An up-to-date catalogue of urinary markers for the management of prostate cancer. Current opinion in urology. 2020 Academic Article GET IT
Aristolochic acid and its effect on different cancers in uro-oncology. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 2
Exploring the molecular basis of sexual dimorphism in bladder cancer. Nature reviews. Urology. 2020 Article GET IT
Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 1
Secretion of severe acute respiratory syndrome coronavirus 2 in urine. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 18
Smoking and bladder cancer: review of the recent literature. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 2
Volume outcome relationship in penile cancer: a systematic review. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 1
The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis. The Journal of urology. 2020 Review GET IT
Times cited: 34
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis. Journal of surgical oncology. 2020 Academic Article GET IT
Times cited: 1
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC). World journal of urology. 2020 Academic Article GET IT
Times cited: 10
The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis. BJU international. 2020 Review GET IT
Times cited: 7
Primary Ta high grade bladder tumors: Determination of the risk of progression. Urologic oncology. 2020 Academic Article GET IT
Times cited: 2
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. European urology focus. 2020 Academic Article GET IT
Times cited: 5
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer. Cells. 2020 Academic Article GET IT
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis. Cancer immunology, immunotherapy : CII. 2020 Information Resource GET IT
Times cited: 47
How to deal with steroids use in the management of metastatic prostate cancer during pandemic. Translational andrology and urology. 2020 Editorial Article GET IT
Times cited: 31
Incidence and preoperative predictors for major complications following radical nephroureterectomy. Translational andrology and urology. 2020 Academic Article GET IT
Times cited: 14
Risk stratification for upper tract urinary carcinoma. Translational andrology and urology. 2020 Review GET IT
Times cited: 45
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder. American journal of clinical oncology. 2020 Academic Article GET IT
Times cited: 1
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. Urologic oncology. 2020 Academic Article GET IT
Times cited: 1
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent. World journal of urology. 2020 Academic Article GET IT
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities. Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 39
Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer. Urologic oncology. 2020 Academic Article GET IT
Times cited: 10
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis. International journal of clinical oncology. 2020 Information Resource GET IT
Trends in Sexual Activity and Associations With All-Cause and Cause-Specific Mortality Among US Adults. The journal of sexual medicine. 2020 Academic Article GET IT
Times cited: 20
Reply by Authors. The Journal of urology. 2020 Comment GET IT
Bladder cancer incidence rates and trends in young adults aged 20-39 years. Urologic oncology. 2020 Academic Article GET IT
Times cited: 1
Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept. World journal of urology. 2020 Letter GET IT
Times cited: 2
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. European urology. 2020 Academic Article GET IT
Times cited: 20
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. European urology. 2020 Academic Article GET IT
Times cited: 24
Bladder sparing landscape for bacillus Calmette-Guérin unresponsive bladder cancer. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 3
Bladder-preserving strategies for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?. Current opinion in urology. 2020 Review GET IT
Times cited: 4
Fibroblast growth factor receptors across urothelial carcinoma landscape. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 1
Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 6
Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 5
Regular Coffee Consumption Is Associated with Lower Regional Adiposity Measured by DXA among US Women. The Journal of nutrition. 2020 Academic Article GET IT
Times cited: 1
The role of taxane-based chemotherapy in the treatment of prostate cancer. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 2
Where do urologists stand in the era of novel coronavirus-2019 disease. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 12
The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group. Surgical oncology. 2020 Academic Article GET IT
Times cited: 10
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials. European urology. 2020 Information Resource GET IT
Times cited: 11
An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer. Expert review of molecular diagnostics. 2020 Information Resource GET IT
Times cited: 5
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. Cancer epidemiology. 2020 Academic Article GET IT
Times cited: 5
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. Urologic oncology. 2020 Academic Article GET IT
Times cited: 11
The clinical pharmacology of the medical treatment for overactive bladder in adults. Expert review of clinical pharmacology. 2020 Information Resource GET IT
Times cited: 1
Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies. European urology focus. 2020 Academic Article GET IT
Times cited: 2
Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference. Journal of psychopharmacology (Oxford, England). 2020 Academic Article GET IT
Times cited: 11
The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy. Arab journal of urology. 2020 Academic Article GET IT
Times cited: 7
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis. International journal of clinical oncology. 2020 Information Resource GET IT
Times cited: 27
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. European urology focus. 2020 Academic Article GET IT
Times cited: 5
A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4. Minerva urology and nephrology. 2020 Review GET IT
Times cited: 2
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 11
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients. European urology focus. 2020 Academic Article GET IT
Times cited: 1
Inflammatory bowel disease and prostate cancer risk: A systematic review. Arab journal of urology. 2020 Review GET IT
Reply by Authors. The Journal of urology. 2020 Comment GET IT
Times cited: 1
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study. World journal of urology. 2020 Academic Article GET IT
Times cited: 2
Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer. BJU international. 2020 Academic Article GET IT
Times cited: 2
Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020 Academic Article GET IT
Times cited: 10
The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy. Urologic oncology. 2020 Academic Article GET IT
Times cited: 1
Catalog of exogenous risk factors for bladder carcinogenesis. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 1
Frontiers in combining immune checkpoint inhibitors for advanced urothelial cancer management. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 1
Novel technologies that change the diagnostic and treatment paradigm in urology: En-bloc as the new treatment standard. Current opinion in urology. 2020 Review GET IT
Times cited: 3
Ureteral and urethral recurrence after radical cystectomy: a systematic review. Current opinion in urology. 2020 Academic Article GET IT
Times cited: 4
Intravesical therapy for bladder cancer in the pandemic of Covid-19. World journal of urology. 2020 Article GET IT
Times cited: 9
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration. World journal of urology. 2020 Academic Article GET IT
Times cited: 1
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?. European urology. 2020 Letter GET IT
Times cited: 31
Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma. Journal of clinical medicine. 2020 Academic Article GET IT
Times cited: 70
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer. Journal of endourology. 2020 Academic Article GET IT
Times cited: 3
[Surgery only? Multimodal treatment for urothelial carcinoma of the bladder]. Aktuelle Urologie. 2020 Academic Article GET IT
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis. World journal of urology. 2020 Academic Article GET IT
Times cited: 17
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities. The Journal of urology. 2020 Academic Article GET IT
Times cited: 26
Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades. Journal of surgical oncology. 2020 Academic Article GET IT
Times cited: 1
Medical practice and placebo response: an inseparable bond?. Wiener klinische Wochenschrift. 2020 Review GET IT
Times cited: 5
Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. International journal of clinical oncology. 2020 Information Resource GET IT
Times cited: 11
A Plea for the Evaluation of the Carbon Footprint of New Mini-invasive Surgical Technologies in Urology. European urology. 2020 Letter GET IT
Times cited: 4
Re: Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer. European urology. 2020 Comment GET IT
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC). Urologic oncology. 2020 Academic Article GET IT
Times cited: 2
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy. Prostate cancer and prostatic diseases. 2020 Academic Article GET IT
Times cited: 27
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer. European urology. 2020 Editorial Article GET IT
Times cited: 14
Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes. International journal of urology : official journal of the Japanese Urological Association. 2020 Academic Article GET IT
Times cited: 2
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020 Academic Article GET IT
Times cited: 2
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC. Future oncology (London, England). 2020 Academic Article GET IT
Times cited: 11
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study. European urology focus. 2020 Academic Article GET IT
Times cited: 1
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis. Prostate cancer and prostatic diseases. 2020 Information Resource GET IT
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma. Urology. 2020 Academic Article GET IT
Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis. Clinical genitourinary cancer. 2020 Information Resource GET IT
Times cited: 2
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis. Urologic oncology. 2020 Academic Article GET IT
Times cited: 2
The prognostic impact of tumour NSD2 expression in advanced prostate cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2020 Academic Article GET IT
An update on systemic therapy for penile cancer. Current opinion in urology. 2020 Review GET IT
Times cited: 3
Epigenetic alterations of testicular germ cell tumours. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 3
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. Urologic oncology. 2020 Academic Article GET IT
Times cited: 15
Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy. Urologic oncology. 2020 Academic Article GET IT
Times cited: 7
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract. Journal of surgical oncology. 2020 Academic Article GET IT
Times cited: 28
Histomorphological analysis of false positive PI-RADS 4 and 5 lesions. Urologic oncology. 2020 Academic Article GET IT
The promise and challenges of neoadjuvant immunotherapy in the management of non-metastatic muscle-invasive bladder cancer. BJU international. 2020 Letter GET IT
Times cited: 1
Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis. Urologic oncology. 2020 Information Resource GET IT
Times cited: 10
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of ⁶⁸Ga-PSMA and ¹¹C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. The Journal of urology. 2020 Academic Article GET IT
Times cited: 14
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. Urologic oncology. 2020 Academic Article GET IT
Times cited: 4
Management of bladder cancer in older patients: Position paper of a SIOG Task Force. Journal of geriatric oncology. 2020 Information Resource GET IT
Times cited: 10
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma. Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 1
Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration. Urologic oncology. 2020 Academic Article GET IT
Times cited: 6
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages. Cancer causes & control : CCC. 2020 Academic Article GET IT
Times cited: 1
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities. Cancer causes & control : CCC. 2020 Academic Article GET IT
Times cited: 4
Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer. Scandinavian journal of urology. 2020 Academic Article GET IT
Times cited: 3
Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society. JMIR research protocols. 2020 Academic Article GET IT
Times cited: 24
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder. World journal of urology. 2020 Academic Article GET IT
Times cited: 2
Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients. Urologic oncology. 2020 Academic Article GET IT
Times cited: 5
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy. Journal of surgical oncology. 2020 Academic Article GET IT
Times cited: 19
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. The Journal of urology. 2020 Academic Article GET IT
Times cited: 20
Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy. Journal of the National Comprehensive Cancer Network : JNCCN. 2020 Academic Article GET IT
Times cited: 14
En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Current opinion in urology. 2020 Information Resource GET IT
Times cited: 11
The changing role of lasers in urologic surgery. Current opinion in urology. 2020 Review GET IT
Times cited: 47
4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study. PloS one. 2019 Academic Article GET IT
Times cited: 4
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy. Urologic oncology. 2019 Academic Article GET IT
Times cited: 1
Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. Clinical genitourinary cancer. 2019 Information Resource GET IT
Times cited: 4
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 1
Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients. European urology focus. 2019 Information Resource GET IT
Times cited: 7
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 6
Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis. Clinical genitourinary cancer. 2019 Information Resource GET IT
Times cited: 6
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy. European urology oncology. 2019 Academic Article GET IT
Times cited: 1
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer. World journal of urology. 2019 Academic Article GET IT
Times cited: 1
Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European urology. 2019 Information Resource GET IT
Times cited: 14
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2019 Academic Article GET IT
Times cited: 32
Clinical outcome of standardized ¹⁷⁷Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks. European journal of nuclear medicine and molecular imaging. 2019 Academic Article GET IT
Times cited: 47
Primary lymphomas of the genitourinary tract: A population-based study. Asian journal of urology. 2019 Academic Article GET IT
Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis. International journal of clinical oncology. 2019 Information Resource GET IT
Times cited: 33
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer. Urologic oncology. 2019 Academic Article GET IT
Times cited: 22
Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia. Prostate cancer and prostatic diseases. 2019 Academic Article GET IT
Times cited: 7
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes. Clinical oncology (Royal College of Radiologists (Great Britain)). 2019 Academic Article GET IT
Times cited: 2
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 9
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases. World journal of urology. 2019 Academic Article GET IT
Times cited: 11
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?. Urologic oncology. 2019 Academic Article GET IT
Times cited: 31
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies. Prostate cancer and prostatic diseases. 2019 Academic Article GET IT
Times cited: 18
Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI?. Clinical radiology. 2019 Academic Article GET IT
Times cited: 4
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Academic Article GET IT
Times cited: 69
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies. Journal of the National Comprehensive Cancer Network : JNCCN. 2019 Academic Article GET IT
Times cited: 17
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Urologic oncology. 2019 Academic Article GET IT
Times cited: 11
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy. Surgical oncology. 2019 Academic Article GET IT
Times cited: 14
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 1
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. Clinical genitourinary cancer. 2019 Academic Article GET IT
Response assessment using [⁶⁸ Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer. The Prostate. 2019 Academic Article GET IT
Times cited: 17
Diagnostic Value of ¹⁸F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma. European urology oncology. 2019 Academic Article GET IT
Times cited: 11
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder. Journal of surgical oncology. 2019 Academic Article GET IT
Times cited: 2
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures: A population-based study. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2019 Academic Article GET IT
Times cited: 5
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis. Clinical genitourinary cancer. 2019 Information Resource GET IT
Times cited: 10
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 14
Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer. European urology. 2019 Article GET IT
What Is the Significance of Variant Histology in Urothelial Carcinoma?. European urology focus. 2019 Information Resource GET IT
Times cited: 24
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?. Urologic oncology. 2019 Academic Article GET IT
Times cited: 5
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?. Journal of clinical medicine. 2019 Academic Article GET IT
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients. World journal of urology. 2019 Academic Article GET IT
Times cited: 1
Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails. European urology. 2019 Editorial Article GET IT
Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2019 Academic Article GET IT
Times cited: 2
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?. European urology oncology. 2019 Academic Article GET IT
Times cited: 1
Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma. International urology and nephrology. 2019 Academic Article GET IT
Times cited: 13
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis. World journal of urology. 2019 Academic Article GET IT
Times cited: 2
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 4
Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary. Clinical genitourinary cancer. 2019 Academic Article GET IT
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. European urology. 2019 Information Resource GET IT
Times cited: 378
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes. Journal of clinical medicine. 2019 Academic Article GET IT
Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies. The Journal of urology. 2019 Academic Article GET IT
Times cited: 12
Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer. Immunotherapy. 2019 Editorial Article GET IT
Times cited: 3
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis. Anticancer research. 2019 Academic Article GET IT
Times cited: 8
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer. The Journal of urology. 2019 Academic Article GET IT
Times cited: 25
Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. Clinical genitourinary cancer. 2019 Information Resource GET IT
Times cited: 10
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality. World journal of urology. 2019 Academic Article GET IT
Times cited: 12
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates. Urologic oncology. 2019 Academic Article GET IT
Times cited: 14
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder. Urologic oncology. 2019 Academic Article GET IT
Times cited: 14
Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis. Urologic oncology. 2019 Information Resource GET IT
Times cited: 9
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nature communications. 2019 Academic Article GET IT
Times cited: 162
Prospective evaluation of the performance of [⁶⁸Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy. European journal of nuclear medicine and molecular imaging. 2019 Academic Article GET IT
Times cited: 33
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. Journal of geriatric oncology. 2019 Academic Article GET IT
Times cited: 8
Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer. Urologic oncology. 2019 Academic Article GET IT
Times cited: 2
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 2
Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis. BJU international. 2019 Academic Article GET IT
Times cited: 15
Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. European urology focus. 2019 Academic Article GET IT
Times cited: 24
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 23
A preoperative nomogram to predict major complications after robot assisted partial nephrectomy (UroCCR-57 study). Urologic oncology. 2019 Academic Article GET IT
Times cited: 3
Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States. Journal of endourology. 2019 Academic Article GET IT
Times cited: 16
The effect of race on survival after local therapy in metastatic prostate cancer patients. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2019 Academic Article GET IT
Times cited: 6361
Performance of [⁶⁸Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis. Prostate cancer and prostatic diseases. 2019 Information Resource GET IT
Times cited: 18
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 10
Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature. Expert review of anticancer therapy. 2019 Information Resource GET IT
Times cited: 2
Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma. Journal of endourology. 2019 Academic Article GET IT
Times cited: 18
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2019 Academic Article GET IT
Times cited: 17
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. Urologic oncology. 2019 Academic Article GET IT
Times cited: 13
Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. International journal of urology : official journal of the Japanese Urological Association. 2019 Information Resource GET IT
Times cited: 40
Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria. Oncology letters. 2019 Academic Article GET IT
Times cited: 10
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU international. 2019 Academic Article GET IT
Times cited: 21
Enhanced Recovery after Radical Cystectomy. Current opinion in urology. 2019 Information Resource GET IT
Times cited: 6
The impact of gender on oncologic outcomes of bladder cancer. Current opinion in urology. 2019 Information Resource GET IT
Times cited: 7
The interaction of gender and smoking on bladder cancer risks. Current opinion in urology. 2019 Information Resource GET IT
Times cited: 14
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 2
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization. World journal of urology. 2019 Academic Article GET IT
Times cited: 10
The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis. Journal of geriatric oncology. 2019 Academic Article GET IT
Times cited: 23
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. World journal of urology. 2019 Academic Article GET IT
Times cited: 23
Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis. World journal of urology. 2019 Information Resource GET IT
Times cited: 7
Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy. BJU international. 2019 Academic Article GET IT
Times cited: 9
Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need. Current treatment options in oncology. 2019 Review GET IT
Times cited: 17
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 17
Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis. International journal of molecular sciences. 2019 Information Resource GET IT
Times cited: 8
Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature. Urologic oncology. 2019 Information Resource GET IT
Times cited: 16
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. European urology. 2019 Academic Article GET IT
Times cited: 14
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients. Cancer epidemiology. 2019 Academic Article GET IT
Times cited: 10
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 13
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study. World journal of urology. 2019 Academic Article GET IT
Times cited: 5
Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis. International journal of urology : official journal of the Japanese Urological Association. 2019 Academic Article GET IT
Times cited: 14
Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. Urologic oncology. 2019 Information Resource GET IT
Times cited: 7
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer. BJU international. 2019 Academic Article GET IT
Times cited: 71
Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2019 Academic Article GET IT
Times cited: 3
Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?. Translational andrology and urology. 2019 Information Resource GET IT
Times cited: 17
The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer. Translational andrology and urology. 2019 Information Resource GET IT
Times cited: 24
Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies. European urology oncology. 2019 Academic Article GET IT
Times cited: 14
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy. Surgical oncology. 2019 Academic Article GET IT
Times cited: 14
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis. Surgical oncology. 2019 Academic Article GET IT
Times cited: 18
Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?. Urologia internationalis. 2019 Academic Article GET IT
Times cited: 3
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?. Cancer. 2019 Academic Article GET IT
Times cited: 18
Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study. European urology. 2019 Comment GET IT
Times cited: 4
Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. Urologic oncology. 2019 Academic Article GET IT
Times cited: 12
Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis. The Journal of urology. 2019 Information Resource GET IT
Times cited: 7
Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study. European urology focus. 2018 Academic Article GET IT
Times cited: 3
Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer. Urologic oncology. 2018 Academic Article GET IT
Times cited: 14
Response assessment using ⁶⁸Ga-PSMA ligand PET in patients undergoing ¹⁷⁷Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer. European journal of nuclear medicine and molecular imaging. 2018 Academic Article GET IT
Times cited: 114
Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder. Urologic oncology. 2018 Academic Article GET IT
Times cited: 12
Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes. European urology. 2018 Information Resource GET IT
Times cited: 33
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Academic Article GET IT
Times cited: 22
Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?. Cancer epidemiology. 2018 Academic Article GET IT
Times cited: 18
Role of serum cholinesterase in patients treated with salvage radical prostatectomy. Urologic oncology. 2018 Academic Article GET IT
Times cited: 5
Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers. Translational andrology and urology. 2018 Editorial Article GET IT
Times cited: 5
Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions. Investigative radiology. 2018 Academic Article GET IT
Times cited: 12
Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial. European urology. 2018 Article GET IT
Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28. European urology. 2018 Article GET IT
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel. European urology focus. 2018 Review GET IT
Times cited: 25
The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. European urology oncology. 2018 Academic Article GET IT
Times cited: 12
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 16
Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. European urology focus. 2018 Academic Article GET IT
Times cited: 12
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients. British journal of cancer. 2018 Academic Article GET IT
Times cited: 9
Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. Urologic oncology. 2018 Academic Article GET IT
Times cited: 9
Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy. Urologic oncology. 2018 Academic Article GET IT
Times cited: 5
What Is Better for Predicting Morbidity of Robotic Partial Nephrectomy-A Score or Your Clinical Judgement?. European urology focus. 2018 Academic Article GET IT
Times cited: 11
Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World journal of urology. 2018 Academic Article GET IT
Times cited: 2
Transcriptomic heterogeneity in multifocal prostate cancer. JCI insight. 2018 Academic Article GET IT
Times cited: 70
Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 7
Focal therapy of prostate cancer. Current opinion in urology. 2018 Academic Article GET IT
Times cited: 11
Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 5
What to do during Bacillus Calmette-Guérin shortage? Valid strategies based on evidence. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 11
A urinary microRNA (miR) signature for diagnosis of bladder cancer. Urologic oncology. 2018 Academic Article GET IT
Times cited: 24
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States. World journal of urology. 2018 Academic Article GET IT
Times cited: 15
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract. World journal of urology. 2018 Academic Article GET IT
Times cited: 4
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. European urology. 2018 Academic Article GET IT
Times cited: 100
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. European urology. 2018 Academic Article GET IT
Times cited: 21
Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 12
The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer. World journal of urology. 2018 Academic Article GET IT
Times cited: 7
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 1
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis. European urology focus. 2018 Academic Article GET IT
Times cited: 18
Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 10
[Palliative surgery for metastatic urothelial cancer]. Aktuelle Urologie. 2018 Review GET IT
Times cited: 1
Transfer of Knowledge in Urology: A Case Study of Jacob Eduard Polak (1818-1891) and the Introduction of Contemporary Techniques of Lithotomy and Lithotripsy from Vienna to Persia in the Mid-19th Century: A New Analysis of Scientific Papers from the 19th Century. Urologia internationalis. 2018 Review GET IT
Times cited: 1
Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 5
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy. World journal of urology. 2018 Academic Article GET IT
Times cited: 15
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. Cancer epidemiology. 2018 Academic Article GET IT
Times cited: 21
Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis. International journal of urology : official journal of the Japanese Urological Association. 2018 Academic Article GET IT
Times cited: 2
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 112
Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer. Urologia internationalis. 2018 Academic Article GET IT
Times cited: 3
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial. European urology. 2018 Article GET IT
Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients. Bladder cancer (Amsterdam, Netherlands). 2018 Academic Article GET IT
Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI). Nordic journal of psychiatry. 2018 Academic Article GET IT
Times cited: 12
Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer. European urology. 2018 Letter GET IT
Times cited: 10
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer. European urology oncology. 2018 Academic Article GET IT
Times cited: 25
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. World journal of urology. 2018 Academic Article GET IT
Times cited: 38
Cost analysis of prostate cancer detection including the prostate health index (phi). World journal of urology. 2018 Academic Article GET IT
Times cited: 7
Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 6
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 35
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study. Urologia internationalis. 2018 Academic Article GET IT
Times cited: 7
Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis. Journal of endourology. 2018 Academic Article GET IT
Times cited: 12
Prostate biopsy: guidelines and evidence. Current opinion in urology. 2018 Review GET IT
Times cited: 21
The evolving role of percutaneous biopsy in renal masses. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 3
A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens. BJU international. 2018 Information Resource GET IT
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer. Urologia internationalis. 2018 Academic Article GET IT
Times cited: 13
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World journal of urology. 2018 Information Resource GET IT
Times cited: 95
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer. BJU international. 2018 Academic Article GET IT
Times cited: 6
The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy. Journal of endourology. 2018 Academic Article GET IT
Times cited: 4
Molecularly-driven precision medicine for advanced bladder cancer. World journal of urology. 2018 Review GET IT
Times cited: 4
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy. World journal of urology. 2018 Academic Article GET IT
Times cited: 2
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. Urologic oncology. 2018 Information Resource GET IT
Times cited: 37
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. European urology oncology. 2018 Academic Article GET IT
Times cited: 52
Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 12
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis. European urology oncology. 2018 Academic Article GET IT
Times cited: 10
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database. European urology focus. 2018 Academic Article GET IT
Times cited: 10
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma. Cancer epidemiology. 2018 Academic Article GET IT
Times cited: 11
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. European urology oncology. 2018 Academic Article GET IT
Times cited: 41
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database. European urology oncology. 2018 Academic Article GET IT
Times cited: 21
Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy. European urology oncology. 2018 Academic Article GET IT
Times cited: 15
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients. European urology oncology. 2018 Academic Article GET IT
Times cited: 13
In-hospital length of stay after major surgical oncological procedures. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Academic Article GET IT
Times cited: 24
Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer. Expert review of anticancer therapy. 2018 Information Resource GET IT
Times cited: 6
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma. Urologic oncology. 2018 Academic Article GET IT
Times cited: 3
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World journal of urology. 2018 Academic Article GET IT
Times cited: 30
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer. World journal of urology. 2018 Academic Article GET IT
Times cited: 14
Robotic assisted simple prostatectomy: recent advances. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 9
Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study. World journal of urology. 2018 Academic Article GET IT
Times cited: 10
A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. Urologic oncology. 2018 Information Resource GET IT
Times cited: 19
Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat. World journal of urology. 2018 Academic Article GET IT
Times cited: 6
The impact of moderate wine consumption on the risk of developing prostate cancer. Clinical epidemiology. 2018 Information Resource GET IT
Times cited: 15
Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages. The Prostate. 2018 Academic Article GET IT
Times cited: 20
A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2018 Academic Article GET IT
Times cited: 17
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer. Urologic oncology. 2018 Academic Article GET IT
Times cited: 12
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy. World journal of urology. 2018 Academic Article GET IT
Times cited: 19
Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 8
Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer. Expert review of molecular diagnostics. 2018 Information Resource GET IT
Times cited: 7
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2018 Academic Article GET IT
Times cited: 13
Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2018 Academic Article GET IT
Times cited: 148
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer. World journal of urology. 2018 Academic Article GET IT
Times cited: 73
More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis. European urology. 2018 Academic Article GET IT
Times cited: 14
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer. Memo. 2018 Information Resource GET IT
Times cited: 23
Analysis of hematological parameters as prognostic markers for toxicity and survival of ²²³Radium treatment. Oncotarget. 2018 Academic Article GET IT
Times cited: 6
Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. Urologic oncology. 2018 Academic Article GET IT
Times cited: 25
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer. Urologic oncology. 2018 Academic Article GET IT
Times cited: 3
Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 13
Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review. Current opinion in urology. 2018 Information Resource GET IT
Times cited: 6
Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram. Prostate cancer and prostatic diseases. 2018 Academic Article GET IT
Times cited: 14
Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. World journal of urology. 2018 Information Resource GET IT
Times cited: 31
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018 Academic Article GET IT
Times cited: 22
Reply by Authors. The Journal of urology. 2018 Comment GET IT
Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. European urology focus. 2018 Academic Article GET IT
Times cited: 22
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature. Clinical genitourinary cancer. 2018 Review GET IT
Times cited: 11
Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients. European urology focus. 2018 Academic Article GET IT
Times cited: 14
Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2018 Review GET IT
Times cited: 11
Neoadjuvant and adjuvant treatment in high-risk prostate cancer. Expert review of clinical pharmacology. 2018 Review GET IT
Times cited: 19
Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy. World journal of urology. 2018 Academic Article GET IT
Times cited: 18
Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis. Bladder cancer (Amsterdam, Netherlands). 2018 Academic Article GET IT
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016". European urology focus. 2018 Review GET IT
Times cited: 112
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study. Prostate cancer and prostatic diseases. 2018 Academic Article GET IT
Times cited: 11
Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. Urologic oncology. 2017 Academic Article GET IT
Times cited: 6
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. European urology focus. 2017 Academic Article GET IT
Times cited: 12
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. Urologic oncology. 2017 Academic Article GET IT
Times cited: 19
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 8
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. European urology focus. 2017 Academic Article GET IT
Times cited: 23
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. European urology. 2017 Academic Article GET IT
Times cited: 22
Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C. Urologic oncology. 2017 Academic Article GET IT
Times cited: 5
Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. Translational andrology and urology. 2017 Information Resource GET IT
Times cited: 41
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder. Translational andrology and urology. 2017 Academic Article GET IT
Times cited: 613
First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy. BJU international. 2017 Academic Article GET IT
Times cited: 18
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies. The Journal of urology. 2017 Academic Article GET IT
Times cited: 10
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer. European urology focus. 2017 Academic Article GET IT
Times cited: 26
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. World journal of urology. 2017 Information Resource GET IT
Times cited: 98
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review. European urology focus. 2017 Academic Article GET IT
Times cited: 117
3D T2-weighted imaging to shorten multiparametric prostate MRI protocols. European radiology. 2017 Academic Article GET IT
Times cited: 36
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder. World journal of urology. 2017 Academic Article GET IT
Times cited: 20
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Urologic oncology. 2017 Academic Article GET IT
Times cited: 11
Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 2
⁶⁸Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making. European journal of nuclear medicine and molecular imaging. 2017 Academic Article GET IT
Times cited: 88
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. European urology focus. 2017 Academic Article GET IT
Times cited: 29
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis. World journal of urology. 2017 Academic Article GET IT
Times cited: 14
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU international. 2017 Academic Article GET IT
Times cited: 38
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT_2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy. BJU international. 2017 Academic Article GET IT
Times cited: 18
Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy. World journal of urology. 2017 Academic Article GET IT
Times cited: 12
ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder. Anticancer research. 2017 Academic Article GET IT
Times cited: 2
Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. European urology. 2017 Article GET IT
Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. Urologic oncology. 2017 Academic Article GET IT
Times cited: 43
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era. International urology and nephrology. 2017 Academic Article GET IT
Times cited: 26
Characteristics and clinical significance of histological variants of bladder cancer. Nature reviews. Urology. 2017 Information Resource GET IT
Times cited: 86
New surgical approaches for clinically high-risk or metastatic prostate cancer. Expert review of anticancer therapy. 2017 Review GET IT
Times cited: 10
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. BJU international. 2017 Academic Article GET IT
Times cited: 13
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urologic oncology. 2017 Academic Article GET IT
Times cited: 1
Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Academic Article GET IT
Times cited: 5
Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy. Urologic oncology. 2017 Academic Article GET IT
Times cited: 3
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. European urology. 2017 Guideline GET IT
Times cited: 443
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T_1-2 N₀ M₀ renal cell carcinoma. World journal of urology. 2017 Academic Article GET IT
Times cited: 15
External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study. Clinical genitourinary cancer. 2017 Academic Article GET IT
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients. World journal of urology. 2017 Academic Article GET IT
Times cited: 16
Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 10
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study. Urology. 2017 Academic Article GET IT
Times cited: 1
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. European urology. 2017 Academic Article GET IT
Times cited: 37
HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas. Pathology oncology research : POR. 2017 Academic Article GET IT
Times cited: 11
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy. Bladder cancer (Amsterdam, Netherlands). 2017 Academic Article GET IT
Times cited: 16
Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis. Urologic oncology. 2017 Academic Article GET IT
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU international. 2017 Review GET IT
Times cited: 108
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. The Journal of urology. 2017 Academic Article GET IT
Times cited: 3
Caveolin-1 Expression in Upper Tract Urothelial Carcinoma. European urology focus. 2017 Academic Article GET IT
Times cited: 2
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma. The Journal of urology. 2017 Academic Article GET IT
Times cited: 36
The Impact of Gender on Tumour Stage in In-House Complications and Choice of Urinary Diversion: Results of the Austrian Cystectomy Registry. Urologia internationalis. 2017 Academic Article GET IT
Times cited: 11
Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer. European urology. 2017 Article GET IT
Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 6
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement. European urology. 2017 Article GET IT
Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. Urology. 2017 Academic Article GET IT
Times cited: 3
Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study. Urologic oncology. 2017 Academic Article GET IT
Times cited: 9
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. European urology. 2017 Review GET IT
Times cited: 102
Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study. Urologic oncology. 2017 Academic Article GET IT
Times cited: 13
Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). Scandinavian journal of urology. 2017 Academic Article GET IT
Times cited: 4
Local Therapy Improves Survival in Metastatic Prostate Cancer. European urology. 2017 Academic Article GET IT
Times cited: 100
Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma. Urologic oncology. 2017 Academic Article GET IT
Times cited: 52
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 25
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. Urologic oncology. 2017 Academic Article GET IT
Times cited: 3
Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Academic Article GET IT
Times cited: 2
Immune therapy meets precision medicine. The Lancet. Oncology. 2017 Comment GET IT
Times cited: 10
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World journal of urology. 2017 Academic Article GET IT
Times cited: 20
ICUD guidelines for upper tract urothelial carcinoma: a state-of-the-art evidence-based guidance for clinical decisions regarding diagnosis, management and treatment. World journal of urology. 2017 Editorial Article GET IT
Times cited: 2
Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. Urologic oncology. 2017 Academic Article GET IT
Times cited: 11
Population-Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment. The Prostate. 2017 Academic Article GET IT
Times cited: 30
Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer. Urologia internationalis. 2017 Academic Article GET IT
Times cited: 10
Electronic Cigarettes: A Wolf in Sheep's Clothing. European urology. 2017 Editorial Article GET IT
Times cited: 2
Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. Journal of surgical oncology. 2017 Academic Article GET IT
Times cited: 30
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer. The Prostate. 2017 Academic Article GET IT
Times cited: 14
Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 7
Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urologic oncology. 2017 Academic Article GET IT
Times cited: 43
Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. World journal of urology. 2017 Review GET IT
Times cited: 22
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 21
Hematopoiesis is prognostic for toxicity and survival of ²²³Radium treatment in patients with metastatic castration-resistant prostate cancer. Hellenic journal of nuclear medicine. 2017 Academic Article GET IT
Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 9
Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study. The Journal of urology. 2016 Academic Article GET IT
Times cited: 46
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 19
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. European urology. 2016 Letter GET IT
Times cited: 3
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. Urologic oncology. 2016 Academic Article GET IT
Times cited: 13
Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?. Translational andrology and urology. 2016 Editorial Article GET IT
Times cited: 15
Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation. Central European journal of urology. 2016 Academic Article GET IT
Times cited: 2
Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 5
Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA. International journal of urology : official journal of the Japanese Urological Association. 2016 Academic Article GET IT
Times cited: 16
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study. World journal of urology. 2016 Academic Article GET IT
Times cited: 8
External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study. Urologic oncology. 2016 Academic Article GET IT
Times cited: 13
Role of salvage lymph node dissection in prostate cancer. Current opinion in urology. 2016 Review GET IT
Times cited: 21
The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients. Prostate cancer and prostatic diseases. 2016 Information Resource GET IT
Times cited: 8
Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography - a systematic review and meta-analysis. European radiology. 2016 Review GET IT
Times cited: 84
Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence. Expert review of molecular diagnostics. 2016 Review GET IT
Times cited: 6
Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2016 Academic Article GET IT
Times cited: 7
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract. World journal of urology. 2016 Academic Article GET IT
Times cited: 4
Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer. Cancer treatment reviews. 2016 Review GET IT
Times cited: 15
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?. Translational andrology and urology. 2016 Review GET IT
Times cited: 117
Building bridges in urothelial carcinoma to face common challenges. Translational andrology and urology. 2016 Editorial Article GET IT
Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma. Translational andrology and urology. 2016 Academic Article GET IT
Times cited: 20
Female with bladder cancer: what and why is there a difference?. Translational andrology and urology. 2016 Review GET IT
Times cited: 36
How to optimally manage elderly bladder cancer patients?. Translational andrology and urology. 2016 Information Resource GET IT
Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?. Translational andrology and urology. 2016 Review GET IT
Times cited: 1
Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery. Translational andrology and urology. 2016 Information Resource GET IT
Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature. Translational andrology and urology. 2016 Information Resource GET IT
Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma. Translational andrology and urology. 2016 Information Resource GET IT
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients. The Prostate. 2016 Academic Article GET IT
Times cited: 20
The surgical management of patients with clinical stage T4 bladder cancer: A single institution experience. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2016 Academic Article GET IT
Times cited: 3
Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer. The Journal of urology. 2016 Academic Article GET IT
Times cited: 41
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma. The Journal of urology. 2016 Academic Article GET IT
Times cited: 17
The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 13
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction. The Journal of urology. 2016 Review GET IT
Times cited: 17
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 42
Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines. Urologic oncology. 2016 Review GET IT
Times cited: 15
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 61
Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non-muscle-invasive high-grade bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 15
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer. Biomolecules. 2016 Academic Article GET IT
Times cited: 49
Update on ablative therapies of renal tumors. Current opinion in urology. 2016 Information Resource GET IT
Times cited: 11
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. Journal of surgical oncology. 2016 Academic Article GET IT
Times cited: 31
Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?. World journal of urology. 2016 Information Resource GET IT
Times cited: 11
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 7
Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database. Urologia internationalis. 2016 Academic Article GET IT
Times cited: 12
Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2016 Academic Article GET IT
Times cited: 239
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. European urology. 2016 Academic Article GET IT
Times cited: 49
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. European urology. 2016 Review GET IT
Times cited: 101
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 26
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nature reviews. Urology. 2016 Information Resource GET IT
Times cited: 46
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. European urology focus. 2016 Academic Article GET IT
Times cited: 16
Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 130
Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy. BJU international. 2016 Academic Article GET IT
Times cited: 17
Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 12
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance. Oncotarget. 2016 Academic Article GET IT
Times cited: 42
The Effect of Obesity on Perioperative Outcomes Following Percutaneous Nephrolithotomy. Journal of endourology. 2016 Academic Article GET IT
Times cited: 10
Predicting the 5-Year Risk of Biochemical Relapse After Postprostatectomy Radiation Therapy in ≥PT2, pN0 Patients With a Comprehensive Tumor Control Probability Model. International journal of radiation oncology, biology, physics. 2016 Academic Article GET IT
Times cited: 12
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. European urology. 2016 Academic Article GET IT
Times cited: 1150
A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer. Cancer treatment reviews. 2016 Review GET IT
Times cited: 16
Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. Urology. 2016 Academic Article GET IT
Times cited: 16
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients. World journal of urology. 2016 Academic Article GET IT
Times cited: 10
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC). World journal of urology. 2016 Academic Article GET IT
Times cited: 15
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World journal of urology. 2016 Academic Article GET IT
Times cited: 39
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract. Urology. 2016 Academic Article GET IT
Times cited: 13
Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer. International journal of radiation oncology, biology, physics. 2016 Academic Article GET IT
Times cited: 14
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World journal of urology. 2016 Academic Article GET IT
Times cited: 26
Urothelial cancer of the upper urinary tract: emerging biomarkers and integrative models for risk stratification. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2016 Review GET IT
Times cited: 13
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World journal of urology. 2016 Information Resource GET IT
Times cited: 40
Re: Failure-Free Survival and Radiotherapy in Patients with Newly Diagnosed Nonmetastatic Prostate Cancer: Data from Patients in the Control Arm of the STAMPEDE Trial. European urology. 2016 Article GET IT
Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. European urology. 2016 Article GET IT
Times cited: 1
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Academic Article GET IT
Times cited: 51
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study. BJU international. 2016 Academic Article GET IT
Times cited: 10
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World journal of urology. 2016 Review GET IT
Times cited: 18
Head-to-head comparison of PI-RADS v2 and PI-RADS v1. European journal of radiology. 2016 Academic Article GET IT
Times cited: 76
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Urologic oncology. 2016 Academic Article GET IT
Times cited: 14
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study. European urology. 2016 Academic Article GET IT
Times cited: 13
The treatment of muscle-invasive bladder cancer in geriatric patients. Current opinion in urology. 2016 Review GET IT
Times cited: 11
Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma. World journal of urology. 2016 Academic Article GET IT
Times cited: 10
Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2016 Academic Article GET IT
Times cited: 38
Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. European urology. 2016 Comment GET IT
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World journal of urology. 2016 Academic Article GET IT
Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Prostate cancer and prostatic diseases. 2016 Academic Article GET IT
Times cited: 11
Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer. The Journal of urology. 2016 Academic Article GET IT
Times cited: 9
Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. Urologic oncology. 2016 Academic Article GET IT
Times cited: 17
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer. The Urologic clinics of North America. 2016 Information Resource GET IT
Times cited: 55
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy. Prostate cancer and prostatic diseases. 2016 Academic Article GET IT
Times cited: 6
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World journal of urology. 2016 Review GET IT
Times cited: 30
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2016 Academic Article GET IT
Times cited: 25
Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study. Bladder cancer (Amsterdam, Netherlands). 2016 Academic Article GET IT
Reducing Complications After Surgery: Still a Long Way To Go. European urology focus. 2016 Editorial Article GET IT
Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time?. Current opinion in urology. 2016 Review GET IT
Times cited: 20
Medical management of benign prostatic hyperplasia: Results from a population-based study. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2016 Academic Article GET IT
Times cited: 13
Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2016 Academic Article GET IT
Times cited: 8
The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance. Mini reviews in medicinal chemistry. 2016 Review GET IT
Times cited: 4
Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience. Clinical genitourinary cancer. 2015 Academic Article GET IT
Times cited: 11
Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches. Urologia. 2015 Review GET IT
Times cited: 11
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. World journal of urology. 2015 Academic Article GET IT
Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis. Urology. 2015 Academic Article GET IT
Times cited: 11
Adrenal Lesions: Progress on All Fronts. European urology focus. 2015 Editorial Article GET IT
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. The Journal of urology. 2015 Academic Article GET IT
Times cited: 17
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Urologic oncology. 2015 Academic Article GET IT
Times cited: 15
The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?. Urologia internationalis. 2015 Academic Article GET IT
Times cited: 10
Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection. Prostate cancer and prostatic diseases. 2015 Academic Article GET IT
Times cited: 29
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU international. 2015 Academic Article GET IT
Times cited: 122
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Academic Article GET IT
Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study. Urology. 2015 Academic Article GET IT
Times cited: 14
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. European urology. 2015 Academic Article GET IT
Times cited: 69
Gender differences in incidence and outcomes of urothelial and kidney cancer. 2015 GET IT
Times cited: 13
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2015 Academic Article GET IT
Times cited: 11
Population-based assessment of cancer-specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis. BJU international. 2015 Academic Article GET IT
Times cited: 12
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer. The Journal of urology. 2015 Academic Article GET IT
Times cited: 14
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups. Urologic oncology. 2015 Academic Article GET IT
Times cited: 19
Gender differences in incidence and outcomes of urothelial and kidney cancer. Nature reviews. Urology. 2015 Review GET IT
Times cited: 50
Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameter. World journal of urology. 2015 Academic Article GET IT
Times cited: 16
Reply to Marco Borghesi, Gaetano La Manna, and Riccardo Schiavina's Letter to the Editor re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51. European urology. 2015 Letter GET IT
The Future of Prostate Cancer Diagnosis: Biomarkers, Biopsy, Both, or Neither?. European urology focus. 2015 Editorial Article GET IT
Times cited: 1
Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015 Academic Article GET IT
Times cited: 22
External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy. The Journal of urology. 2015 Academic Article GET IT
Times cited: 15
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. European urology. 2015 Review GET IT
Times cited: 234
Re: nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT. European urology. 2015 Comment GET IT
Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?. Current opinion in urology. 2015 Information Resource GET IT
Times cited: 13
Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038. European urology. 2015 Article GET IT
Times cited: 1
Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology. Molecular carcinogenesis. 2015 Academic Article GET IT
Times cited: 23
Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker. The Prostate. 2015 Academic Article GET IT
Times cited: 19
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU international. 2015 Academic Article GET IT
Times cited: 12
Construct, content and face validity of the camera handling trainer (CHT): a new E-BLUS training task for 30° laparoscope navigation skills. World journal of urology. 2015 Academic Article GET IT
Times cited: 12
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. Urologic oncology. 2015 Academic Article GET IT
Times cited: 11
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. European urology. 2015 Guideline GET IT
Times cited: 379
Serum Adiponectin Predicts Cancer-specific Survival of Patients with Renal Cell Carcinoma. European urology focus. 2015 Academic Article GET IT
Times cited: 5
ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy. The Journal of urology. 2015 Academic Article GET IT
Times cited: 18
Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. European urology. 2015 Academic Article GET IT
Times cited: 18
Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. European urology. 2015 Academic Article GET IT
Times cited: 37
Upper urinary tract disease: what we know today and unmet needs. Translational andrology and urology. 2015 Information Resource GET IT
Times cited: 26
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. European urology focus. 2015 Academic Article GET IT
Times cited: 27
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. European urology focus. 2015 Academic Article GET IT
Times cited: 4
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU international. 2015 Academic Article GET IT
Times cited: 24
Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?. World journal of urology. 2015 Academic Article GET IT
Times cited: 10
Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes. European urology focus. 2015 Information Resource GET IT
Times cited: 48
There Are Cooler Ways to Die Than Smoking: Urologists of the World, Unite Against This Health Care Tragedy. European urology focus. 2015 Editorial Article GET IT
Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. World journal of urology. 2015 Academic Article GET IT
Times cited: 12
Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?. BJU international. 2015 Academic Article GET IT
Times cited: 24
TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma. World journal of urology. 2015 Academic Article GET IT
Times cited: 11
Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World journal of urology. 2015 Academic Article GET IT
Times cited: 10
Partial nephrectomy driven by cavitron ultrasonic surgical aspirator under zero ischemia: a pilot study. World journal of urology. 2015 Academic Article GET IT
Times cited: 3
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World journal of urology. 2015 Academic Article GET IT
Times cited: 44
Histopathology and prognosis of de novo bladder tumors following solid organ transplantation. World journal of urology. 2015 Academic Article GET IT
Times cited: 6
Penile rehabilitation after radical prostatectomy: does it work?. Translational andrology and urology. 2015 Review GET IT
Times cited: 29
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. The Journal of urology. 2015 Academic Article GET IT
Times cited: 30
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. World journal of urology. 2015 Academic Article GET IT
Times cited: 11
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2015 Academic Article GET IT
Times cited: 11
Novel biomarkers to predict response and prognosis in localized bladder cancer. The Urologic clinics of North America. 2015 Information Resource GET IT
Times cited: 8
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU international. 2015 Academic Article GET IT
Times cited: 24
Kidney-sparing surgery for upper tract urothelial cancer. Current opinion in urology. 2015 Review GET IT
Times cited: 17
Lynch Syndrome: A Primer for Urologists and Panel Recommendations. The Journal of urology. 2015 Review GET IT
Times cited: 41
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. European urology. 2015 Information Resource GET IT
Times cited: 168
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?. European urology. 2015 Academic Article GET IT
Times cited: 33
Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease. Urology. 2015 Academic Article GET IT
Times cited: 25
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients. BJU international. 2015 Academic Article GET IT
Times cited: 19
Management of advanced bladder cancer in the era of targeted therapies. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2015 Review GET IT
Times cited: 10
Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study. The Journal of urology. 2015 Academic Article GET IT
Times cited: 4
Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis. Asian Pacific journal of cancer prevention : APJCP. 2015 Review GET IT
Times cited: 35
Diagnosis and management of upper tract urothelial carcinoma. Hematology/oncology clinics of North America. 2014 Information Resource GET IT
Times cited: 13
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus. Urologia internationalis. 2014 Review GET IT
Times cited: 104
Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. Clinical genitourinary cancer. 2014 Academic Article GET IT
Times cited: 28
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. European urology. 2014 Review GET IT
Times cited: 125
Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group". Wiener klinische Wochenschrift. 2014 Academic Article GET IT
Times cited: 2
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?. Urologic oncology. 2014 Academic Article GET IT
Times cited: 42
Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 24
The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma. DNA and cell biology. 2014 Academic Article GET IT
Times cited: 2
Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. European urology. 2014 Information Resource GET IT
Times cited: 43
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. The Journal of urology. 2014 Academic Article GET IT
Times cited: 32
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Academic Article GET IT
[Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Academic Article GET IT
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy. World journal of urology. 2014 Academic Article GET IT
Times cited: 14
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma. Urology. 2014 Academic Article GET IT
Times cited: 16
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model. Urologic oncology. 2014 Academic Article GET IT
Times cited: 21
Contemporary 90-day mortality rates after radical cystectomy in the elderly. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 63
Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU international. 2014 Academic Article GET IT
Times cited: 29
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. European urology. 2014 Academic Article GET IT
Times cited: 249
The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urologic oncology. 2014 Academic Article GET IT
Times cited: 51
Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice. Urologic oncology. 2014 Review GET IT
Times cited: 36
Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity. PloS one. 2014 Academic Article GET IT
Times cited: 30
[Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Review GET IT
Times cited: 6
Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. Cancer. 2014 Academic Article GET IT
Times cited: 14
Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 28
Bladder cancer: the curious case of a not so rare disease. Current opinion in urology. 2014 Editorial Article GET IT
Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2014 Academic Article GET IT
Times cited: 28
Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer. Current opinion in urology. 2014 Review GET IT
Times cited: 20
[Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2014 Review GET IT
Times cited: 5
European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. European urology. 2014 Editorial Article GET IT
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study. The Lancet. Oncology. 2014 Academic Article GET IT
Times cited: 306
Conditional survival after radical nephroureterectomy for upper tract carcinoma. European urology. 2014 Academic Article GET IT
Times cited: 51
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma. British journal of cancer. 2014 Academic Article GET IT
Times cited: 60
Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma. Korean journal of urology. 2014 Academic Article GET IT
Times cited: 10
Innovations in diagnostic imaging of localized prostate cancer. World journal of urology. 2014 Review GET IT
Times cited: 19
Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer. European urology. 2014 Article GET IT
Times cited: 1
Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis. BJU international. 2014 Academic Article GET IT
Times cited: 43
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Review GET IT
Times cited: 63
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. The Journal of urology. 2014 Academic Article GET IT
Times cited: 20
Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study. World journal of urology. 2014 Academic Article GET IT
Times cited: 11
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. Urologic oncology. 2014 Academic Article GET IT
Times cited: 25
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. European urology. 2014 Academic Article GET IT
Times cited: 142
Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib. Cancer biology & therapy. 2014 Academic Article GET IT
Times cited: 30
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment. British journal of cancer. 2014 Academic Article GET IT
Times cited: 24
Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. BJU international. 2014 Academic Article GET IT
Times cited: 28
Re: Global effects of smoking, of quitting, and of taxing tobacco. European urology. 2014 Article GET IT
Times cited: 5
Comparison of complications from radical cystectomy between old-old versus oldest-old patients. Urologia internationalis. 2014 Academic Article GET IT
Times cited: 23
Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness. Urologic oncology. 2014 Academic Article GET IT
Times cited: 30
Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU international. 2014 Academic Article GET IT
Times cited: 35
More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. European urology. 2014 Academic Article GET IT
Times cited: 143
Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer. Current urology reports. 2014 Review GET IT
Times cited: 11
Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Urology. 2014 Academic Article GET IT
Times cited: 23
Predictors of survival in patients with disease recurrence after radical nephroureterectomy. BJU international. 2014 Academic Article GET IT
Times cited: 18
Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis. World journal of urology. 2014 Review GET IT
Times cited: 57
Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy. Urologic oncology. 2014 Academic Article GET IT
Times cited: 20
Prospective external validation of a bladder cancer detection model. The Journal of urology. 2014 Academic Article GET IT
Times cited: 22
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic oncology. 2014 Academic Article GET IT
Times cited: 17
Lower urinary tract symptoms in patients with liver cirrhosis. World journal of urology. 2014 Academic Article GET IT
Times cited: 3
Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. Urology journal. 2014 Academic Article GET IT
Times cited: 19
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Current urology reports. 2014 Review GET IT
Times cited: 39
Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions. World journal of urology. 2014 Academic Article GET IT
Times cited: 28
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 15
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. The journal of sexual medicine. 2014 Review GET IT
Times cited: 119
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis. BJU international. 2014 Academic Article GET IT
Times cited: 22
Is there any evidence of a "July effect" in patients undergoing major cancer surgery?. Canadian journal of surgery. Journal canadien de chirurgie. 2014 Academic Article GET IT
Times cited: 30
Optimal results come from optimal surgery and optimal (neoadjuvant) systemic therapy. BJU international. 2014 Editorial Article GET IT
Times cited: 1
How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center. Journal of endourology. 2014 Academic Article GET IT
Times cited: 18
Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors. European journal of radiology. 2014 Academic Article GET IT
Times cited: 40
Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 38
Diagnosis of renal tumors by in vivo proton magnetic resonance spectroscopy. World journal of urology. 2014 Academic Article GET IT
Times cited: 10
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer. International journal of cancer. 2014 Academic Article GET IT
Times cited: 17
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU international. 2014 Academic Article GET IT
Times cited: 45
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. European urology. 2014 Review GET IT
Times cited: 181
Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer. World journal of urology. 2014 Academic Article GET IT
Times cited: 30
Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratory. World journal of urology. 2014 Academic Article GET IT
Times cited: 5
Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World journal of urology. 2014 Academic Article GET IT
Times cited: 12
Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urologic oncology. 2014 Academic Article GET IT
Times cited: 22
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology. 2014 Academic Article GET IT
Times cited: 59
Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. European urology. 2014 Academic Article GET IT
Times cited: 26
The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. European urology. 2014 Academic Article GET IT
Times cited: 51
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urologic oncology. 2014 Academic Article GET IT
Times cited: 24
External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy. Journal of endourology. 2014 Academic Article GET IT
Times cited: 26
Highlights from the first symposium on upper tract urothelial carcinoma. Urologic oncology. 2014 Review GET IT
Times cited: 12
Local tumor destruction in renal cell carcinoma--an inpatient population-based study. Urologic oncology. 2014 Academic Article GET IT
Times cited: 10
Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy. BJU international. 2014 Academic Article GET IT
Times cited: 26
Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2014 Academic Article GET IT
Times cited: 8
Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Urologic oncology. 2014 Academic Article GET IT
Times cited: 21
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU international. 2014 Information Resource GET IT
Times cited: 166
Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA surgery. 2014 Academic Article GET IT
Times cited: 103
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. European urology. 2013 Academic Article GET IT
Times cited: 111
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. European urology. 2013 Academic Article GET IT
Times cited: 20
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer. Human pathology. 2013 Academic Article GET IT
Times cited: 38
Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. European urology. 2013 Academic Article GET IT
Times cited: 121
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 18
Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. European urology. 2013 Academic Article GET IT
Times cited: 69
Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer. BJU international. 2013 Academic Article GET IT
Times cited: 12
Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC). BJU international. 2013 Academic Article GET IT
Times cited: 15
Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score. BJU international. 2013 Academic Article GET IT
Times cited: 16
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 49
Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years. Urology. 2013 Academic Article GET IT
Times cited: 35
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. European urology. 2013 Academic Article GET IT
Times cited: 99
Re: impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: M. Hagiwara, E. Kikuchi, N. Tanaka, K. Matsumoto, H. Ide, A. Miyajima, T. Masuda, S. Nakamura and M. Oya J Urol 2013; 189: 2062-2068. The Journal of urology. 2013 Article GET IT
Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. The Journal of urology. 2013 Review GET IT
Times cited: 68
Segmental ureterectomy for upper tract urothelial carcinoma: two procedures with different indications. Urologic oncology. 2013 Article GET IT
Times cited: 3
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. International journal of radiation oncology, biology, physics. 2013 Academic Article GET IT
Times cited: 11
Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Urologic oncology. 2013 Academic Article GET IT
Times cited: 27
High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urologic oncology. 2013 Academic Article GET IT
Times cited: 39
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. The Prostate. 2013 Academic Article GET IT
Times cited: 159
Novel urinary markers for detection of bladder cancer-are we failing?. The Journal of urology. 2013 Editorial Article GET IT
Times cited: 4
Frequent truncating mutations of STAG2 in bladder cancer. Nature genetics. 2013 Academic Article GET IT
Times cited: 168
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. European urology. 2013 Academic Article GET IT
Times cited: 88
Words of wisdom: Re: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trial. European urology. 2013 Article GET IT
Times cited: 1
Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort. World journal of urology. 2013 Academic Article GET IT
Times cited: 35
BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. The Journal of urology. 2013 Academic Article GET IT
Times cited: 54
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer. World journal of urology. 2013 Academic Article GET IT
Times cited: 27
[BCG maintenance treatment: an optimal scheme?]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2013 Editorial Article GET IT
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013 Academic Article GET IT
Times cited: 22
Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?. The Journal of urology. 2013 Academic Article GET IT
Times cited: 24
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. European urology. 2013 Academic Article GET IT
Times cited: 85
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013 Academic Article GET IT
Times cited: 102
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?. Urologic oncology. 2013 Academic Article GET IT
Times cited: 6
Urine markers for detection and surveillance of bladder cancer. Urologic oncology. 2013 Information Resource GET IT
Times cited: 68
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. The Journal of urology. 2013 Academic Article GET IT
Times cited: 43
Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis. BJU international. 2013 Academic Article GET IT
Times cited: 20
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy. Prostate cancer and prostatic diseases. 2013 Academic Article GET IT
Times cited: 12
Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis. International journal of urology : official journal of the Japanese Urological Association. 2013 Academic Article GET IT
Times cited: 16
Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. The Journal of urology. 2013 Academic Article GET IT
Times cited: 17
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. British journal of cancer. 2013 Academic Article GET IT
Times cited: 191
Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. European urology. 2013 Academic Article GET IT
Times cited: 26
Bladder cancer: is contrast-enhanced CT necessary for following up NMIBC?. Nature reviews. Urology. 2013 Comment GET IT
[Randomized controlled trials terminated prematurely: beneficial therapy effects]. Der Urologe. Ausg. A. 2013 Review GET IT
Times cited: 1
Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent. International urology and nephrology. 2013 Review GET IT
Times cited: 13
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project). BJU international. 2013 Academic Article GET IT
Times cited: 55
Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses. World journal of urology. 2013 Academic Article GET IT
Times cited: 11
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. European urology. 2013 Review GET IT
Times cited: 138
Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma. The Journal of urology. 2013 Academic Article GET IT
Times cited: 29
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European urology. 2013 Academic Article GET IT
Times cited: 55
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. European urology. 2013 Academic Article GET IT
Times cited: 20
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. The Journal of urology. 2013 Academic Article GET IT
Times cited: 78
Effect of statin use on outcomes of non-muscle-invasive bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 22
In-hospital mortality and failure-to-rescue rates after radical cystectomy. BJU international. 2013 Academic Article GET IT
Times cited: 25
[The likelihood ratio: estimation of the impact of a diagnostic test on treatment decision]. Der Urologe. Ausg. A. 2013 Review GET IT
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis. Clinical genitourinary cancer. 2013 Academic Article GET IT
Times cited: 13
Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. European urology. 2013 Information Resource GET IT
Times cited: 106
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. European urology. 2013 Guideline GET IT
Times cited: 1069
Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time. BJU international. 2013 Academic Article GET IT
Times cited: 22
Sociodemographic disparities in the treatment of small renal masses. BJU international. 2013 Academic Article GET IT
Times cited: 20
Words of wisdom. Re: Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. European urology. 2013 Article GET IT
Times cited: 2
[Kaplan-Meier analysis in urological practice]. Der Urologe. Ausg. A. 2013 Review GET IT
Times cited: 2
The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy. World journal of urology. 2013 Academic Article GET IT
Times cited: 2
EAU guidelines on robotic and single-site surgery in urology. European urology. 2013 Guideline GET IT
Times cited: 124
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. European urology. 2013 Information Resource GET IT
Times cited: 81
[Use and interpretation of the number needed to treat in urological practice]. Der Urologe. Ausg. A. 2013 Review GET IT
Lymphadenectomy for bladder cancer at the time of radical cystectomy. European urology. 2013 Review GET IT
Times cited: 39
Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL. World journal of urology. 2013 Academic Article GET IT
Times cited: 2
A systematic review of the volume-outcome relationship for radical prostatectomy. European urology. 2013 Review GET IT
Times cited: 176
The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?. World journal of urology. 2013 Review GET IT
Times cited: 8
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis. BJU international. 2013 Academic Article GET IT
Times cited: 2
Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. European urology. 2013 Academic Article GET IT
Times cited: 57
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma. Therapeutic advances in urology. 2013 Academic Article GET IT
Times cited: 17
[Confidence intervals and p-values in urology: interpretation and misinterpretation]. Der Urologe. Ausg. A. 2013 Academic Article GET IT
Times cited: 1
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. The Journal of urology. 2013 Academic Article GET IT
Times cited: 37
Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology. 2013 Academic Article GET IT
Times cited: 41
European guidelines on upper tract urothelial carcinomas: 2013 update. European urology. 2013 Guideline GET IT
Times cited: 350
Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Cancer. 2013 Academic Article GET IT
Times cited: 16
Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. European urology. 2013 Letter GET IT
Times cited: 5
Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU international. 2013 Academic Article GET IT
Times cited: 30
Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study. BJU international. 2013 Academic Article GET IT
Times cited: 15
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU international. 2013 Academic Article GET IT
Times cited: 17
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU international. 2013 Academic Article GET IT
Times cited: 86
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. European journal of cancer. 2013 Academic Article GET IT
Times cited: 116
The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Urologic oncology. 2013 Academic Article GET IT
Times cited: 35
[Use of PubMed to improve evidence-based medicine in routine urological practice]. Der Urologe. Ausg. A. 2013 Academic Article GET IT
Times cited: 3
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer epidemiology. 2013 Academic Article GET IT
Times cited: 155
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. The Journal of urology. 2013 Academic Article GET IT
Times cited: 22
Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation. International journal of urology : official journal of the Japanese Urological Association. 2013 Academic Article GET IT
Times cited: 32
Renal cancer therapy: going forward by going backward?. European urology. 2013 Editorial Article GET IT
Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?. Urologic oncology. 2013 Academic Article GET IT
Times cited: 27
Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. The Journal of urology. 2013 Academic Article GET IT
Times cited: 28
Assays for prostate cancer : changing the screening paradigm?. Molecular diagnosis & therapy. 2013 Academic Article GET IT
Times cited: 5
Words of wisdom: re: a prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. European urology. 2013 Comment GET IT
Times cited: 8
Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder. The Journal of urology. 2013 Academic Article GET IT
Times cited: 51
Screening for bladder cancer: rationale, limitations, whom to target, and perspectives. European urology. 2013 Review GET IT
Times cited: 45
Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?. International braz j urol : official journal of the Brazilian Society of Urology. 2013 Academic Article GET IT
Times cited: 7
Robot-assisted vs. laparoscopic partial nephrectomy: utilization rates and perioperative outcomes. International braz j urol : official journal of the Brazilian Society of Urology. 2013 Academic Article GET IT
Times cited: 18
Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2013 Academic Article GET IT
Times cited: 191
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 13
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. The Journal of urology. 2012 Academic Article GET IT
Times cited: 29
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World journal of urology. 2012 Academic Article GET IT
Times cited: 41
Sex disparities in cancer mortality: the risks of being a man in the United States. The Journal of urology. 2012 Academic Article GET IT
Times cited: 31
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. European urology. 2012 Academic Article GET IT
Times cited: 71
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 41
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. European urology. 2012 Academic Article GET IT
Times cited: 60
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. British journal of cancer. 2012 Academic Article GET IT
Times cited: 31
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World journal of urology. 2012 Academic Article GET IT
Times cited: 30
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis. Cancer causes & control : CCC. 2012 Academic Article GET IT
Times cited: 28
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 19
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. The Journal of urology. 2012 Academic Article GET IT
Times cited: 111
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. The Journal of urology. 2012 Academic Article GET IT
Times cited: 46
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. The Journal of urology. 2012 Academic Article GET IT
Times cited: 61
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. The Journal of urology. 2012 Academic Article GET IT
Times cited: 33
Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis. BJU international. 2012 Academic Article GET IT
Times cited: 7
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis. International journal of urology : official journal of the Japanese Urological Association. 2012 Academic Article GET IT
Times cited: 15
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines. International journal of urology : official journal of the Japanese Urological Association. 2012 Academic Article GET IT
Times cited: 17
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers. European urology. 2012 Conference Paper GET IT
Times cited: 177
Urothelial carcinoma of the bladder and the upper tract: disparate twins. The Journal of urology. 2012 Review GET IT
Times cited: 181
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World journal of urology. 2012 Academic Article GET IT
Times cited: 24
The changing face of renal cell carcinoma: the impact of systematic genetic sequencing on our understanding of this tumor's biology. European urology. 2012 Editorial Article GET IT
Times cited: 4
Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study. European urology. 2012 Article GET IT
Times cited: 1
Cost-effective treatment of low-risk carcinoma not invading bladder muscle. BJU international. 2012 Academic Article GET IT
Times cited: 22
In-hospital mortality and failure to rescue after cytoreductive nephrectomy. European urology. 2012 Academic Article GET IT
Times cited: 49
Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer. European urology. 2012 Letter GET IT
Times cited: 23
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 60
Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. European urology. 2012 Review GET IT
Times cited: 61
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. Urologic oncology. 2012 Academic Article GET IT
Times cited: 9
[Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors]. Der Urologe. Ausg. A. 2012 Review GET IT
Times cited: 2
Demographic analysis of randomized controlled trials in bladder cancer. BJU international. 2012 Review GET IT
Times cited: 6
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. European urology. 2012 Academic Article GET IT
Times cited: 110
Collaborative research networks as a platform for virtual multidisciplinary, international approach to managing difficult clinical cases: an example from the Upper Tract Urothelial Carcinoma Collaboration. European urology. 2012 Letter GET IT
Times cited: 10
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. International journal of urology : official journal of the Japanese Urological Association. 2012 Academic Article GET IT
Times cited: 43
Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. European urology. 2012 Academic Article GET IT
Times cited: 60
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2012 Academic Article GET IT
Times cited: 44
The effect of gender on nephrectomy perioperative outcomes: a national survey. The Canadian journal of urology. 2012 Academic Article GET IT
Times cited: 5
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?. World journal of urology. 2012 Academic Article GET IT
Times cited: 14
Epidemiology and risk factors of urothelial bladder cancer. European urology. 2012 Review GET IT
Times cited: 1099
Uptake of laparoscopic radical nephroureterectomy in France: a 2003-2011 national practice report. European urology. 2012 Letter GET IT
Times cited: 2
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. The Prostate. 2012 Academic Article GET IT
Times cited: 38
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. European urology. 2012 Academic Article GET IT
Times cited: 42
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. European urology. 2012 Academic Article GET IT
Times cited: 106
National trends and disparities in the use of minimally invasive adult pyeloplasty. The Journal of urology. 2012 Academic Article GET IT
Times cited: 34
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 24
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 57
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 37
Magnetic resonance imaging-targeted prostate biopsy: back to the future. European urology. 2012 Editorial Article GET IT
Times cited: 11
Biomarkers in personalised treatment of renal-cell carcinoma. The Lancet. Oncology. 2012 Letter GET IT
Times cited: 14
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). European urology. 2012 Academic Article GET IT
Times cited: 72
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. European urology. 2012 Academic Article GET IT
Times cited: 97
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 53
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. European urology. 2012 Academic Article GET IT
Times cited: 33
Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?. The Journal of urology. 2012 Academic Article GET IT
Times cited: 2
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology. 2012 Academic Article GET IT
Times cited: 41
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. The Journal of urology. 2012 Academic Article GET IT
Times cited: 106
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?. The journal of sexual medicine. 2012 Academic Article GET IT
Times cited: 24
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. European urology. 2012 Review GET IT
Times cited: 322
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. European urology. 2012 Review GET IT
Times cited: 342
[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]. Der Urologe. Ausg. A. 2012 Review GET IT
Times cited: 16
Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU international. 2012 Academic Article GET IT
Times cited: 23
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU international. 2012 Academic Article GET IT
Times cited: 37
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. The Journal of urology. 2012 Academic Article GET IT
Times cited: 36
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. International journal of urology : official journal of the Japanese Urological Association. 2012 Academic Article GET IT
Times cited: 72
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PloS one. 2012 Academic Article GET IT
Times cited: 75
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. European urology. 2012 Academic Article GET IT
Times cited: 135
A review of integrated staging systems for renal cell carcinoma. European urology. 2012 Review GET IT
Times cited: 61
Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy. European urology. 2012 Letter GET IT
Times cited: 10
Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma. European urology. 2012 Letter GET IT
Times cited: 14
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU international. 2012 Review GET IT
Times cited: 32
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. The Journal of urology. 2012 Academic Article GET IT
Times cited: 45
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. Urology. 2012 Academic Article GET IT
Times cited: 10
Biomolecular predictors of urothelial cancer behavior and treatment outcomes. Current urology reports. 2012 Review GET IT
Times cited: 47
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. European urology. 2012 Academic Article GET IT
Times cited: 115
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU international. 2012 Academic Article GET IT
Times cited: 35
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2012 Academic Article GET IT
Times cited: 44
Leapfrog volume thresholds and perioperative complications after radical prostatectomy. Cancer. 2012 Academic Article GET IT
Times cited: 17
Novel approaches to improve prostate cancer diagnosis and management in early-stage disease. BJU international. 2012 Academic Article GET IT
Times cited: 15
Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder. BJU international. 2012 Academic Article GET IT
Times cited: 13
Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. European urology. 2012 Letter GET IT
Times cited: 52
High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. Journal of endourology. 2012 Academic Article GET IT
Times cited: 51
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. European urology. 2012 Review GET IT
Times cited: 271
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis. BJU international. 2012 Academic Article GET IT
Times cited: 17
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. European urology. 2012 Academic Article GET IT
Times cited: 67
Discharge patterns after radical cystectomy: contemporary trends in the United States. The Journal of urology. 2012 Academic Article GET IT
Times cited: 2
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study. International journal of radiation oncology, biology, physics. 2012 Academic Article GET IT
Times cited: 24
Treatment management of small renal masses in the 21st century: a paradigm shift. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 74
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis. BJU international. 2012 Academic Article GET IT
Times cited: 12
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload. BJU international. 2012 Academic Article GET IT
Times cited: 11
Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer. 2012 Academic Article GET IT
Times cited: 50
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. European urology. 2012 Academic Article GET IT
Times cited: 30
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. European urology. 2012 Review GET IT
Times cited: 170
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. European urology. 2012 Academic Article GET IT
Times cited: 147
Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. European urology. 2012 Academic Article GET IT
Times cited: 116
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. The Journal of urology. 2012 Academic Article GET IT
Times cited: 41
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. European urology. 2012 Letter GET IT
Times cited: 135
Laparoscopic and open partial nephrectomy: complication comparison using the Clavien system. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2012 Academic Article GET IT
Times cited: 28
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. European urology. 2011 Academic Article GET IT
Times cited: 298
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. European urology. 2011 Academic Article GET IT
Times cited: 50
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. European journal of cancer. 2011 Academic Article GET IT
Times cited: 37
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU international. 2011 Academic Article GET IT
Times cited: 67
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 51
Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. The Journal of urology. 2011 Academic Article GET IT
Times cited: 35
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. The Journal of urology. 2011 Academic Article GET IT
Times cited: 35
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy. International urology and nephrology. 2011 Academic Article GET IT
Times cited: 7
A non-cancer-related survival benefit is associated with partial nephrectomy. European urology. 2011 Academic Article GET IT
Times cited: 119
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. Urology. 2011 Academic Article GET IT
Times cited: 16
Tissue-based molecular markers for renal cell carcinoma. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2011 Review GET IT
Times cited: 26
Discharge patterns after radical prostatectomy in the United States of America. Urologic oncology. 2011 Academic Article GET IT
Times cited: 18
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 59
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy. BJU international. 2011 Academic Article GET IT
Times cited: 13
Comprehensive handbook for developing a bladder cancer cystectomy database. Urologic oncology. 2011 Academic Article GET IT
Times cited: 4
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. BJU international. 2011 Academic Article GET IT
Times cited: 22
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC). BJU international. 2011 Information Resource GET IT
Times cited: 20
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. European urology. 2011 Academic Article GET IT
Times cited: 52
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. The Journal of urology. 2011 Academic Article GET IT
Times cited: 12
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. World journal of urology. 2011 Academic Article GET IT
Times cited: 21
Does low-risk prostate cancer detection change with repeat biopsies?. European urology. 2011 Letter GET IT
Times cited: 1
Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2011 Academic Article GET IT
Times cited: 25
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer research. 2011 Academic Article GET IT
Times cited: 159
Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. Archivos espanoles de urologia. 2011 Information Resource GET IT
Times cited: 21
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. European urology. 2011 Academic Article GET IT
Times cited: 128
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA. BJU international. 2011 Academic Article GET IT
Times cited: 29
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis. The Journal of urology. 2011 Academic Article GET IT
Times cited: 31
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner. The Journal of urology. 2011 Academic Article GET IT
Times cited: 10
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy. BJU international. 2011 Academic Article GET IT
Times cited: 56
Does partial nephrectomy at an academic institution result in better outcomes?. World journal of urology. 2011 Academic Article GET IT
Times cited: 6
Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study. European urology. 2011 Academic Article GET IT
Times cited: 42
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urologic oncology. 2011 Academic Article GET IT
Times cited: 51
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States. Cancer. 2011 Academic Article GET IT
Times cited: 20
Open radical prostatectomy in the elderly: a case for concern?. BJU international. 2011 Academic Article GET IT
Times cited: 12
The effect of insurance status on outcomes after partial nephrectomy. International urology and nephrology. 2011 Academic Article GET IT
Times cited: 10
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 289
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC. BJU international. 2011 Review GET IT
Times cited: 49
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin. Urology annals. 2011 Academic Article GET IT
Times cited: 23
Can we apply nomograms derived in the United States to European patients? Yes, we can!. European urology. 2011 Editorial Article GET IT
Times cited: 7
Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer. 2011 Academic Article GET IT
Times cited: 32
Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU international. 2011 Academic Article GET IT
Times cited: 31
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU international. 2011 Academic Article GET IT
Times cited: 52
A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy. BJU international. 2011 Academic Article GET IT
Times cited: 10
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial. BJU international. 2011 Academic Article GET IT
Times cited: 19
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. European urology. 2011 Academic Article GET IT
Times cited: 28
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. BJU international. 2011 Academic Article GET IT
Times cited: 37
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study. The Journal of urology. 2011 Academic Article GET IT
Times cited: 8
Urothelial carcinoma. World journal of urology. 2011 Editorial Article GET IT
Times cited: 2
Immunohistochemical biomarkers for bladder cancer prognosis. International journal of urology : official journal of the Japanese Urological Association. 2011 Academic Article GET IT
Times cited: 54
Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. European urology. 2011 Review GET IT
Times cited: 104
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder. World journal of urology. 2011 Academic Article GET IT
Times cited: 10
Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed. Cancer. 2011 Editorial Article GET IT
Times cited: 7
Prognostic factors for upper urinary tract urothelial carcinoma. Nature reviews. Urology. 2011 Review GET IT
Times cited: 83
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. European urology. 2011 Review GET IT
Times cited: 223
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. European urology. 2011 Academic Article GET IT
Times cited: 62
Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy. Urologic oncology. 2011 Academic Article GET IT
Times cited: 1
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 27
Epigenetics in prostate cancer: biologic and clinical relevance. European urology. 2011 Review GET IT
Times cited: 161
Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World journal of urology. 2011 Review GET IT
Times cited: 51
Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. European urology. 2011 Review GET IT
Times cited: 129
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urologia internationalis. 2011 Academic Article GET IT
Times cited: 19
Impact of gender on bladder cancer incidence, staging, and prognosis. World journal of urology. 2011 Information Resource GET IT
Times cited: 149
Stage pT0 after radical cystectomy: are all patients equal?. European urology. 2011 Letter GET IT
Times cited: 2
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study. Cancer causes & control : CCC. 2011 Academic Article GET IT
Times cited: 35
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU international. 2011 Academic Article GET IT
Times cited: 165
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World journal of urology. 2011 Academic Article GET IT
Times cited: 46
Tumor markers in prostate cancer I: blood-based markers. Acta oncologica (Stockholm, Sweden). 2011 Information Resource GET IT
Times cited: 152
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy. World journal of urology. 2011 Academic Article GET IT
Times cited: 20
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. The Journal of urology. 2011 Academic Article GET IT
Times cited: 54
Clinical experience and critical evaluation of the role of everolimus in advanced renal cell carcinoma. Open access journal of urology. 2011 Review GET IT
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 14
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy. BJU international. 2011 Academic Article GET IT
Times cited: 18
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU international. 2011 Academic Article GET IT
Times cited: 29
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy. BJU international. 2011 Academic Article GET IT
Times cited: 70
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World journal of urology. 2011 Academic Article GET IT
Times cited: 37
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 49
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment. The Journal of urology. 2011 Academic Article GET IT
Times cited: 14
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urologic oncology. 2011 Academic Article GET IT
Times cited: 25
A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study. The Prostate. 2011 Academic Article GET IT
Times cited: 23
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. European urology. 2011 Academic Article GET IT
Times cited: 35
Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?. Therapeutic advances in urology. 2011 Academic Article GET IT
Times cited: 20
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. European urology. 2011 Academic Article GET IT
Times cited: 182
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. Journal of endourology. 2011 Academic Article GET IT
Times cited: 14
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer. 2011 Academic Article GET IT
Times cited: 58
Conditional survival predictions after surgery for patients with penile carcinoma. Cancer. 2011 Academic Article GET IT
Times cited: 29
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 11
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 26
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU international. 2011 Academic Article GET IT
Times cited: 57
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU international. 2011 Academic Article GET IT
Times cited: 140
The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer. European urology. 2011 Editorial Article GET IT
Times cited: 3
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011 Academic Article GET IT
Times cited: 61
Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder. The Journal of urology. 2011 Academic Article GET IT
Times cited: 9
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World journal of urology. 2011 Academic Article GET IT
Times cited: 59
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU international. 2011 Academic Article GET IT
Times cited: 131
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis. Cancer. 2011 Academic Article GET IT
Times cited: 46
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 64
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma. The Journal of urology. 2010 Academic Article GET IT
Times cited: 21
Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer. BJU international. 2010 Academic Article GET IT
Times cited: 26
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology. 2010 Academic Article GET IT
Times cited: 24
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study. BJU international. 2010 Academic Article GET IT
Times cited: 11
Management of upper urinary tract urothelial carcinoma. Expert review of anticancer therapy. 2010 Review GET IT
Times cited: 8
Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder. BJU international. 2010 Academic Article GET IT
Times cited: 25
Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder. Human pathology. 2010 Academic Article GET IT
Times cited: 20
Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression. BJU international. 2010 Academic Article GET IT
Times cited: 18
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU international. 2010 Academic Article GET IT
Times cited: 22
Evidence-based comparison of robotic and open radical prostatectomy. TheScientificWorldJournal. 2010 Review GET IT
Times cited: 18
Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU international. 2010 Academic Article GET IT
Times cited: 66
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU international. 2010 Academic Article GET IT
Times cited: 116
Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. BJU international. 2010 Review GET IT
Times cited: 39
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. European urology. 2010 Academic Article GET IT
Times cited: 223
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends. The Journal of urology. 2010 Academic Article GET IT
Times cited: 32
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study. Annals of surgical oncology. 2010 Academic Article GET IT
Times cited: 18
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. European urology. 2010 Academic Article GET IT
Times cited: 137
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urologic oncology. 2010 Academic Article GET IT
Times cited: 48
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. Urology. 2010 Academic Article GET IT
Times cited: 49
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World journal of urology. 2010 Academic Article GET IT
Times cited: 87
Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder. BJU international. 2010 Academic Article GET IT
Times cited: 71
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU international. 2010 Academic Article GET IT
Times cited: 27
Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. The Journal of urology. 2010 Academic Article GET IT
Times cited: 48
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma. Annals of surgical oncology. 2010 Academic Article GET IT
Times cited: 27
Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. European urology. 2010 Review GET IT
Times cited: 88
Factors affecting outcome in renal cell carcinoma. Current opinion in urology. 2010 Review GET IT
Times cited: 6
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. The Journal of urology. 2010 Academic Article GET IT
Times cited: 53
Tissue-based molecular markers for bladder cancer. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2010 Review GET IT
Times cited: 10
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer. 2010 Academic Article GET IT
Times cited: 61
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer. 2010 Academic Article GET IT
Times cited: 65
[Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2010 Review GET IT
Times cited: 6
Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?. European urology. 2010 Academic Article GET IT
Times cited: 101
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. European urology. 2010 Review GET IT
Times cited: 132
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 122
The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. European urology. 2010 Academic Article GET IT
Times cited: 156
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. The Journal of urology. 2010 Academic Article GET IT
Times cited: 49
Statistical consideration for clinical biomarker research in bladder cancer. Urologic oncology. 2010 Information Resource GET IT
Times cited: 130
Clinical outcome of primary versus secondary bladder carcinoma in situ. The Journal of urology. 2010 Academic Article GET IT
Times cited: 36
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. The Journal of urology. 2010 Academic Article GET IT
Times cited: 149
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. The Journal of urology. 2010 Academic Article GET IT
Times cited: 23
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. The Journal of urology. 2010 Academic Article GET IT
Times cited: 157
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. The Journal of urology. 2010 Academic Article GET IT
Times cited: 176
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urologic oncology. 2010 Academic Article GET IT
Times cited: 60
Update on intravesical agents for non-muscle-invasive bladder cancer. Immunotherapy. 2010 Information Resource GET IT
Times cited: 19
Bladder cancer: nomogram aids clinical decision making after radical cystectomy. Nature reviews. Urology. 2010 Article GET IT
Times cited: 11
[How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2010 Academic Article GET IT
Times cited: 4
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. The Journal of urology. 2010 Academic Article GET IT
Times cited: 87
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. The Journal of urology. 2010 Academic Article GET IT
Times cited: 53
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 29
Effect of the number of biopsy cores on prostate cancer detection and staging. Future oncology (London, England). 2010 Review GET IT
Times cited: 11
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. The Journal of urology. 2010 Academic Article GET IT
Times cited: 79
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU international. 2010 Academic Article GET IT
Times cited: 127
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma. BJU international. 2010 Academic Article GET IT
Times cited: 41
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology. 2010 Academic Article GET IT
Times cited: 45
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 66
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. European urology. 2010 Academic Article GET IT
Times cited: 32
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. The Journal of urology. 2010 Academic Article GET IT
Times cited: 21
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. European journal of cancer. 2010 Academic Article GET IT
Times cited: 138
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?. Urologic oncology. 2010 Academic Article GET IT
Times cited: 43
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. European urology. 2010 Academic Article GET IT
Times cited: 142
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. The Journal of urology. 2010 Academic Article GET IT
Times cited: 50
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 124
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urologic oncology. 2010 Academic Article GET IT
Times cited: 78
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer. 2009 Academic Article GET IT
Times cited: 44
Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU international. 2009 Academic Article GET IT
Times cited: 55
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. European urology. 2009 Academic Article GET IT
Times cited: 70
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology. 2009 Academic Article GET IT
Times cited: 67
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2009 Academic Article GET IT
Times cited: 101
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Urology. 2009 Academic Article GET IT
Times cited: 77
Critical review of prostate cancer predictive tools. Future oncology (London, England). 2009 Review GET IT
Times cited: 153
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. European urology. 2009 Academic Article GET IT
Times cited: 120
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU international. 2009 Academic Article GET IT
Times cited: 110
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 57
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology. 2009 Academic Article GET IT
Times cited: 43
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2009 Academic Article GET IT
Times cited: 114
Conditional survival predictions after nephrectomy for renal cell carcinoma. The Journal of urology. 2009 Academic Article GET IT
Times cited: 42
Prediction of delayed graft function after renal transplantation. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2009 Academic Article GET IT
Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Urology. 2009 Academic Article GET IT
Times cited: 13
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. The Journal of urology. 2009 Academic Article GET IT
Times cited: 105
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. European urology. 2009 Academic Article GET IT
Times cited: 136
Prospective questionnaire-based evaluation of the prevalence of urinary incontinence in women with chronic cough. Urologia internationalis. 2009 Academic Article GET IT
Times cited: 7
A delay in radical nephroureterectomy can lead to upstaging. BJU international. 2009 Academic Article GET IT
Times cited: 67
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma. BJU international. 2009 Academic Article GET IT
Times cited: 15
Radiographic predictors of need for angiographic embolization after traumatic renal injury. The Journal of trauma. 2009 Academic Article GET IT
Times cited: 45
Words of wisdom. Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V. European urology. 2009 Comment GET IT
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. The Journal of urology. 2009 Academic Article GET IT
Times cited: 60
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy. Journal of endourology. 2009 Academic Article GET IT
Times cited: 1
p53 expression in patients with advanced urothelial cancer of the urinary bladder. BJU international. 2009 Academic Article GET IT
Times cited: 56
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?. Urology. 2009 Academic Article GET IT
Times cited: 12
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology. 2009 Academic Article GET IT
Times cited: 52
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. Urology. 2009 Academic Article GET IT
Times cited: 26
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. The Journal of urology. 2009 Academic Article GET IT
Times cited: 176
p53 predictive value for pT1-2 N0 disease at radical cystectomy. The Journal of urology. 2009 Academic Article GET IT
Times cited: 47
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. European urology. 2009 Academic Article GET IT
Times cited: 132
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. European journal of cancer. 2009 Academic Article GET IT
Times cited: 101
Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. European urology. 2009 Letter GET IT
Times cited: 53
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. European urology. 2009 Academic Article GET IT
Times cited: 47
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?. European urology. 2009 Academic Article GET IT
Times cited: 125
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. The Journal of urology. 2009 Academic Article GET IT
Times cited: 16
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. The Journal of urology. 2009 Academic Article GET IT
Times cited: 10
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. Urology. 2009 Academic Article GET IT
Times cited: 28
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma. BJU international. 2009 Academic Article GET IT
Times cited: 15
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence. The Prostate. 2009 Academic Article GET IT
Times cited: 37
CEACAM1: a novel urinary marker for bladder cancer detection. European urology. 2009 Academic Article GET IT
Times cited: 37
A population based assessment of perioperative mortality after cystectomy for bladder cancer. The Journal of urology. 2009 Academic Article GET IT
Times cited: 107
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. The Journal of urology. 2009 Academic Article GET IT
Times cited: 74
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. Urology. 2009 Academic Article GET IT
Times cited: 12
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. The Journal of urology. 2009 Academic Article GET IT
Times cited: 145
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma). BJU international. 2009 Academic Article GET IT
Times cited: 12
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. European urology. 2009 Academic Article GET IT
Times cited: 138
Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009 Academic Article GET IT
Times cited: 232
Use of nomograms for predictions of outcome in patients with advanced bladder cancer. Therapeutic advances in urology. 2009 Academic Article GET IT
Times cited: 24
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009 Academic Article GET IT
Times cited: 689
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU international. 2009 Academic Article GET IT
Times cited: 52
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 27
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. Journal of the National Cancer Institute. 2009 Academic Article GET IT
Times cited: 127
Bladder cancer in the elderly. Urologic oncology. 2009 Review GET IT
Times cited: 155
Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review. International braz j urol : official journal of the Brazilian Society of Urology. 2009 Review GET IT
Times cited: 20
Prediction of cancer relapse after prostatectomy: use the postoperative nomogram. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Letter GET IT
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81. European urology. 2009 Article GET IT
Words of wisdom. Re: Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol 2008;179:1830-7; discussion 1837. European urology. 2009 Article GET IT
Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?. Urologic oncology. 2008 Academic Article GET IT
Times cited: 62
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 243
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU international. 2008 Academic Article GET IT
Times cited: 103
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU international. 2008 Academic Article GET IT
Times cited: 54
An updated catalog of prostate cancer predictive tools. Cancer. 2008 Information Resource GET IT
Times cited: 213
Screening for bladder cancer using urine-based tumor markers. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2008 Review GET IT
Times cited: 6
Screening for prostate cancer: an update. The Canadian journal of urology. 2008 Review GET IT
Times cited: 39
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2008 Information Resource GET IT
Times cited: 41
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Urology. 2008 Academic Article GET IT
Times cited: 63
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men. International journal of urology : official journal of the Japanese Urological Association. 2008 Academic Article GET IT
Times cited: 5
Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection. Urology. 2008 Academic Article GET IT
Times cited: 14
Thirty-day mortality after nephrectomy: clinical implications for informed consent. European urology. 2008 Academic Article GET IT
Times cited: 48
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 36
External validation of the updated partin tables in a cohort of French and Italian men. International journal of radiation oncology, biology, physics. 2008 Academic Article GET IT
Times cited: 45
Genomics: a preview of genomic medicine. BJU international. 2008 Academic Article GET IT
Times cited: 7
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables. International journal of radiation oncology, biology, physics. 2008 Academic Article GET IT
Times cited: 14
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU international. 2008 Academic Article GET IT
Times cited: 63
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU international. 2008 Academic Article GET IT
Times cited: 123
Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236). Archives of internal medicine. 2008 Comment GET IT
Times cited: 1
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology. 2008 Academic Article GET IT
Times cited: 62
Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators. European urology. 2008 Comment GET IT
Times cited: 2
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Urology. 2008 Academic Article GET IT
Times cited: 34
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008 Academic Article GET IT
Times cited: 28
Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. European urology. 2008 Academic Article GET IT
Outcomes for patients with pT0 disease after radical nephroureterectomy for upper-tract urothelial carcinoma. BJU international. 2008 Academic Article GET IT
Times cited: 3
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. Urology. 2008 Academic Article GET IT
Times cited: 12
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men. International journal of cancer. 2008 Academic Article GET IT
Times cited: 34
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. European urology. 2008 Editorial Article GET IT
Times cited: 2
External validation of the updated Partin tables in a cohort of North American men. The Journal of urology. 2008 Academic Article GET IT
Times cited: 38
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Review GET IT
Times cited: 194
Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European urology. 2008 Editorial Article GET IT
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. European urology. 2008 Academic Article GET IT
Times cited: 58
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 73
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study. BJU international. 2008 Academic Article GET IT
Times cited: 12
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma. The Journal of trauma. 2008 Academic Article GET IT
Times cited: 36
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 35
Editorial comment on: Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker. European urology. 2008 Editorial Article GET IT
Times cited: 1
Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. European urology. 2008 Editorial Article GET IT
Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. European urology. 2008 Editorial Article GET IT
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer. BJU international. 2008 Academic Article GET IT
Times cited: 12
Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study. European urology. 2008 Letter GET IT
Times cited: 13
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. European urology. 2008 Letter GET IT
Times cited: 35
Inventory of prostate cancer predictive tools. Current opinion in urology. 2008 Review GET IT
Times cited: 63
Features and outcomes of patients with grade IV renal injury. BJU international. 2008 Academic Article GET IT
Times cited: 32
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. The Journal of urology. 2008 Academic Article GET IT
Times cited: 62
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU international. 2008 Academic Article GET IT
Times cited: 120
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU international. 2008 Academic Article GET IT
Times cited: 24
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. The journal of sexual medicine. 2008 Academic Article GET IT
Times cited: 40
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases. BJU international. 2008 Academic Article GET IT
Times cited: 29
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects. Biomarkers in medicine. 2008 Academic Article GET IT
Times cited: 7
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 46
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening. The journal of sexual medicine. 2008 Academic Article GET IT
Times cited: 7
Predicting survival after radical cystectomy for bladder cancer. BJU international. 2008 Review GET IT
Times cited: 40
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy. The Journal of urology. 2008 Academic Article GET IT
Times cited: 24
Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12. European urology. 2008 Editorial Article GET IT
Times cited: 3
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma. BJU international. 2008 Academic Article GET IT
Times cited: 22
Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 40
Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. BJU international. 2008 Academic Article GET IT
Times cited: 36
Editorial comment on: Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. European urology. 2008 Editorial Article GET IT
Perspectives on prostate cancer biomarkers. European urology. 2008 Editorial Article GET IT
Times cited: 11
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology. 2008 Academic Article GET IT
Times cited: 52
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma. The Journal of urology. 2008 Academic Article GET IT
Times cited: 16
Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis. Archives of internal medicine. 2008 Letter GET IT
Times cited: 4
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening. The journal of sexual medicine. 2008 Academic Article GET IT
Times cited: 10
Herbal/hormonal dietary supplement possibly associated with prostate cancer progression. 2008 GET IT
Times cited: 7
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer. 2008 Academic Article GET IT
Times cited: 158
Nomograms for bladder cancer. European urology. 2008 Review GET IT
Times cited: 75
Critical evaluation of urinary markers for bladder cancer detection and monitoring. Reviews in urology. 2008 Academic Article GET IT
Molecular markers in bladder cancer. Current opinion in urology. 2008 Review GET IT
Times cited: 67
Using biopsy to detect prostate cancer. Reviews in urology. 2008 Academic Article GET IT
The search for better prognostic factors for men treated for localized prostate cancer continues. European urology. 2007 Editorial Article GET IT
Times cited: 2
Screening for prostate cancer in 2007: the PSA era and its challenges are not over. European urology. 2007 Editorial Article GET IT
Times cited: 8
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU international. 2007 Academic Article GET IT
Times cited: 107
New circulating biomarkers for prostate cancer. Prostate cancer and prostatic diseases. 2007 Review GET IT
Times cited: 63
Prostate volume and adverse prostate cancer features: fact not artifact. European journal of cancer. 2007 Academic Article GET IT
Times cited: 60
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. European urology. 2007 Academic Article GET IT
Times cited: 13
[What are the differences between American and French urologists?]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2007 Academic Article GET IT
Times cited: 2
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. European urology. 2007 Academic Article GET IT
Times cited: 32
Survivin: a promising biomarker for detection and prognosis of bladder cancer. World journal of urology. 2007 Review GET IT
Times cited: 80
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer. BJU international. 2007 Review GET IT
Times cited: 54
Challenges of cancer biomarker profiling. European urology. 2007 Review GET IT
Times cited: 171
Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 24
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. BJU international. 2007 Academic Article GET IT
Times cited: 22
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU international. 2007 Academic Article GET IT
Times cited: 24
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU international. 2007 Academic Article GET IT
Times cited: 56
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. Urology. 2007 Academic Article GET IT
Times cited: 59
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 174
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Human pathology. 2007 Academic Article GET IT
Times cited: 69
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. International journal of cancer. 2007 Academic Article GET IT
Times cited: 41
Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. The Journal of urology. 2007 Academic Article GET IT
Times cited: 23
Blood biomarkers for prostate cancer detection and prognosis. Future oncology (London, England). 2007 Review GET IT
Times cited: 20
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 42
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin. BJU international. 2007 Academic Article GET IT
Times cited: 26
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. The Prostate. 2007 Academic Article GET IT
Times cited: 121
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. International journal of radiation oncology, biology, physics. 2007 Academic Article GET IT
Times cited: 18
Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale. The Journal of trauma. 2007 Academic Article GET IT
Times cited: 110
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. European urology. 2007 Academic Article GET IT
Times cited: 18
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer. 2007 Academic Article GET IT
Times cited: 114
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 35
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2007 Academic Article GET IT
Times cited: 115
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. The Journal of urology. 2007 Academic Article GET IT
Times cited: 36
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 178
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma. The Journal of urology. 2007 Academic Article GET IT
Times cited: 122
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. The Lancet. Oncology. 2007 Academic Article GET IT
Times cited: 176
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 55
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder. Urologic oncology. 2007 Academic Article GET IT
Times cited: 42
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. Urologic oncology. 2007 Academic Article GET IT
Times cited: 29
Selecting patients for immediate cystectomy. Reviews in urology. 2007 Academic Article GET IT
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 117
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL. European urology. 2006 Academic Article GET IT
Times cited: 13
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. The Journal of urology. 2006 Academic Article GET IT
Times cited: 517
Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 194
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. European urology. 2006 Academic Article GET IT
Times cited: 132
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. The Journal of urology. 2006 Academic Article GET IT
Times cited: 166
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology. 2006 Academic Article GET IT
Times cited: 27
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. European urology. 2006 Academic Article GET IT
Times cited: 73
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. The Journal of urology. 2006 Academic Article GET IT
Times cited: 80
Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Human pathology. 2006 Academic Article GET IT
Times cited: 87
Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence. The Journal of urology. 2006 Academic Article GET IT
Times cited: 27
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU international. 2006 Academic Article GET IT
Times cited: 106
Precystectomy nomogram for prediction of advanced bladder cancer stage. European urology. 2006 Academic Article GET IT
Times cited: 126
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. European urology. 2006 Academic Article GET IT
Times cited: 243
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. The Journal of urology. 2006 Academic Article GET IT
Times cited: 135
Cancer specific outcomes in patients with pT0 disease following radical cystectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 40
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer. Cancer. 2006 Academic Article GET IT
Times cited: 53
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU international. 2006 Academic Article GET IT
Times cited: 107
Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml. European urology. 2005 Academic Article GET IT
Times cited: 27
Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor. 2005 GET IT
Times cited: 19
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. The Journal of urology. 2005 Academic Article GET IT
Times cited: 37
Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. The Prostate. 2005 Academic Article GET IT
Times cited: 63
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder. European urology. 2005 Academic Article GET IT
Times cited: 14
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 238
Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology. 2005 Academic Article GET IT
Times cited: 74
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. The Journal of urology. 2005 Academic Article GET IT
Times cited: 126
Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. European urology. 2005 Academic Article GET IT
Times cited: 24
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients. The Canadian journal of urology. 2005 Academic Article GET IT
Times cited: 5
Anomalies of the wolffian duct derivatives encountered at radical prostatectomy. Reviews in urology. 2005 Academic Article GET IT
BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia. Reviews in urology. 2005 Academic Article GET IT
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer. Urology. 2005 Academic Article GET IT
Times cited: 18
Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology. 2004 Academic Article GET IT
Times cited: 167
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. The Journal of urology. 2004 Academic Article GET IT
Times cited: 25
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy. BJU international. 2004 Academic Article GET IT
Times cited: 41
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy. Urology. 2004 Academic Article GET IT
Times cited: 17
Molecular diagnosis of prostate cancer. Current urology reports. 2004 Review GET IT
Times cited: 4
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy. The Journal of urology. 2004 Academic Article GET IT
Times cited: 43
Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy. Urology. 2004 Academic Article GET IT
Times cited: 38
Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. The Journal of urology. 2004 Academic Article GET IT
Times cited: 60
Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 100
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. The Journal of urology. 2004 Academic Article GET IT
Times cited: 231
Predictors of prostate cancer after initial negative systematic 12 core biopsy. The Journal of urology. 2004 Academic Article GET IT
Times cited: 101
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology. 2004 Academic Article GET IT
Times cited: 47
Stage specific lymph node metastasis mapping in radical cystectomy specimens. The Journal of urology. 2004 Academic Article GET IT
Times cited: 184
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004 Academic Article GET IT
Times cited: 558
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 143
Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. The Journal of urology. 2004 Academic Article GET IT
Times cited: 101
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. The Journal of urology. 2004 Academic Article GET IT
Times cited: 100
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. European urology. 2004 Academic Article GET IT
Times cited: 41
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 260
Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer. 2004 Academic Article GET IT
Times cited: 160
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. The Journal of urology. 2004 Academic Article GET IT
Times cited: 155
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. Reviews in urology. 2004 Academic Article GET IT
Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. The Journal of urology. 2004 Academic Article GET IT
Times cited: 40
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy. The Journal of urology. 2003 Academic Article GET IT
Times cited: 45
The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer. The Journal of urology. 2003 Academic Article GET IT
Times cited: 22
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. The Journal of urology. 2003 Academic Article GET IT
Times cited: 300
Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma. Cancer. 2003 Letter GET IT
Times cited: 1
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. Cancer research. 2003 Academic Article GET IT
Times cited: 31
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. The Journal of urology. 2003 Academic Article GET IT
Times cited: 70
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 182
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer research. 2003 Academic Article GET IT
Times cited: 65
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology. 2003 Academic Article GET IT
Times cited: 106
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urology. 2003 Academic Article GET IT
Times cited: 52
Biochemical staging of prostate cancer. The Urologic clinics of North America. 2003 Review GET IT
Times cited: 30
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 45
Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. The Journal of urology. 2003 Academic Article GET IT
Times cited: 81
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. Urology. 2003 Academic Article GET IT
Times cited: 32
Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer. Reviews in urology. 2003 Academic Article GET IT
Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma. Cancer. 2002 Academic Article GET IT
Times cited: 26
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Cancer research. 2002 Academic Article GET IT
Times cited: 36
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. The Journal of urology. 2002 Academic Article GET IT
Times cited: 78
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 131
Metastatic transitional cell carcinoma of the urinary bladder to the shoulder girdle. 2002 GET IT
Sural Nerve Interposition Grafting during Radical Prostatectomy. Reviews in urology. 2002 Academic Article GET IT
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer. 2001 Academic Article GET IT
Times cited: 73
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology. 2001 Academic Article GET IT
Times cited: 208
Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer. 2001 Academic Article GET IT
Times cited: 48
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 27
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 176
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. The Journal of urology. 2001 Academic Article GET IT
Times cited: 106
Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology. 2001 Academic Article GET IT
Times cited: 134
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. The Journal of urology. 2001 Academic Article GET IT
Times cited: 207
Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Cancer research. 2001 Academic Article GET IT
Times cited: 81
Characteristics of normal prostate vascular anatomy as displayed by power Doppler. The Prostate. 2001 Academic Article GET IT
Times cited: 38
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 172
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology. 2001 Academic Article GET IT
Times cited: 74
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. Cancer research. 2000 Academic Article GET IT
Times cited: 32
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Urology. 2000 Academic Article GET IT
Times cited: 71
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy. Urology. 2000 Academic Article GET IT
Times cited: 29
Gene therapy for prostate cancer. Reviews in urology. 2000 Academic Article GET IT
Vaccine-based immunotherapy for prostate cancer. Reviews in urology. 2000 Academic Article GET IT
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?. Urology. 1999 Academic Article GET IT
Times cited: 36
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. Urology. 1999 Academic Article GET IT
Times cited: 40
A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. The Journal of urology. 1999 Academic Article GET IT
Times cited: 34
Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. The Journal of urology. 1999 Academic Article GET IT
Times cited: 58
Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis. The Journal of urology. 1998 Academic Article GET IT
Times cited: 14
Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of a prospective, randomized, single-blinded clinical trial. The Journal of urology. 1998 Academic Article GET IT
Times cited: 28
Prostate specific antigen density of the transition zone for early detection of prostate cancer. The Journal of urology. 1998 Academic Article GET IT
Times cited: 128
Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate. Techniques in urology. 1998 Academic Article GET IT
Times cited: 26
Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. Urology. 1997 Academic Article GET IT
Times cited: 73
Silicone cream occlusive dressing in postoperative care of chemical peels. International journal of dermatology. 1997 Letter GET IT

more ...

less ...

Background

education and training

M.D., University of Vienna Faculty of Medicine (Austria) 1998

Contact

full name

Shahrokh Shariat

primary email

sfs2002@med.cornell.edu

VIVO Weill Cornell Medical College

Shahrokh Shariat Adjunct Clinical Associate Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name

primary email